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SYNTHESIS AND FUNCTIONALITY STUDY OF
NOVEL BIOMIMETIC N-GLYCAN POLYMERS

KA KEUNG CHAN

ABSTRACT

Cell

surface

carbohydrates,

existing as

glycoproteins,

glycolipids,

and

proteoglycans, often serve as receptors to relay critical interactions and trigger crucial
signaling events in many biological processes. Glycan recognition is deeply involved in
immune surveillance, response and can provide abundant opportunities to discover the

molecular mechanism and potential therapeutic or diagnostic approaches for various
diseases. Many useful functionalities can be achieved by developing synthetic glycans to
mimic natural carbohydrates. Over the recent decade, glycopolymers, polymers with
pendant carbohydrates, have continued to prove usefulness in various applications across

different scientific disciplines. For example, glycopolymers can be used as biomimetic

glycoligands to study protein functions, modify nanomaterials, and target immune cells to
yield tailored immune responses toward a desired outcome. In this dissertation, I employed
cyanoxyl-mediated free radical polymerization (CMFRP) for a straightforward synthesis

of chain-end functionalized N-glycan polymer-based biomimetic glycoligands with the
focus on controlling the chain-end functional group, carbohydrate ligand moiety, linkage

and density, then demonstrated their various achievable functionalities.
With UV-photoactivatable covalent crosslinking chemistry in mind, novel aryl

azide chain-end functionalized N-glycan polymers were synthesized for affinity assisted
photo-labeling of proteins that are specific to the carbohydrate moieties expressed on the

polymer backbone. The synthestic glycopolymers have demonstrated promising

v

capabilities for specifically labeling proteins and will be useful multivalent ligands for
identifying protein targets and their affinity of interest.

Secondly, the glycopolymer’s ability to achieve complexation of single-wall carbon
nanotubes (SWCNTs) was demonstrated in aqueous environment. Particularly, it was

discovered that disaccharide lactose-containing polymers with dense carbohydrate pendent
units and long backbones allowed for the best performance, which revealed the synergistic

effects of carbohydrate identity and polymer chain length on introducing water solubility
to SWCNTs. It was discovered that that the dispersion of SWCNTs with the novel N-glycan

polymers yielded even greater water solubility than that with the well-known and
conventional dispersant - DNA-(GT)20.

Finally, the immunomodulation effects of the novel synthetic N-glycan polymers
were compared with model compound, lipopolysaccharide, upon treatment of mouse

macrophages using a series of newly developed high-throughput multiplex assays on

micropillar chips and 384-pillar plates platforms, which are validated using conventional
96-well plates.
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CHAPTER I

INTRODUCTION

1.1 Glycans

Glycans are one of the fundamental classes of biomolecules, alongside nucleic acids,

proteins, and lipids, that make up all living systems.1 They play a significant part in the
etiology of all human diseases in which their biological roles can be divided into two broad

categories: (1) their structural and modulatory aspects and (2) their unique specificity to be
recognized by glycan-binding proteins.2 Cell surface glycans interact specifically with

molecules in the matrix or with other glycans on the shared surface, this property

contributes to their role in cell-cell interactions where glycan recognition becomes deeply
involved in immune response mechanisms.3 In the diversity of nature, glycans exist in
staggering numbers and complexities, the case is just as much so in human bodies even

though human glycans are built primarily from only 10 monosaccharides: glucose (Glc),

galactose (Gal), mannose (Man), sialic acid (SA), N-acetylglucosamine (GlcNAc), Nacetylgalactosamine (GalNAc), fucose (Fuc), xylose (Xyl), glucuronic acid (GlcA), and
iduronic acid (IdoA).4 Glycans are characterized by a remarkable structural diversity due
to the nature and sequence of the constituent units, the possible branching of the

1

carbohydrate chains and the configuration and position of glycosidic linkages.5 It is this
diversity that allows glycans to perform a vast array of biological functions and play

important roles in various physiological and pathophysiological events. The recognition of
glycans by glycan-binding proteins with high affinity and unique specificity is pivotal in
the expansion of glycan-related clinically relevant diagnostics and therapeutic research. By

understanding glycan’s structural and functional components, it can be rationalized that
one can reconstitute carbohydrate epitopes in order to mimic their authentic compositions

and presentations, which will allow for the potential to initiate desired responses from a
target immune cell.6

2

Figure 1.1. Mammalian cell surface and cellular glycoconjugates. (A) Monosaccharide building blocks of glycoconjugate glycans (B)
Neu5Ac is the major sialic acid in humans. Cited from Ref. 7.

3

1.1.1

Glycosylation

Glycosylation is one of the most common and complex post-translation
modifications that affects significant protein properties, namely stability, folding,

molecular recognition, and immunogenicity.8 There are two common types of
glycosylation, N-linked and O-linked. O-linked glycosylation refers to where the sugar

molecule is attached to an oxygen atom of a serine (Ser) or threonine (Thr) residue of a
protein, while N-linked glycosylation refers to where the sugar molecule is attached to a

nitrogen atom of an asparagine (Asn) residue of a protein.9 Although both are typically

found in proteins processed through the ER and Golgi, N-linked has been generally
accepted to be the most frequent protein modification in eukaryotes.9
In nature, N-glycans are biosynthesized and processed by a series of

glycosyltransferases and glycohydrolases in a non-template-directed manner, contributing
to heterogeneous glycoforms that impact protein folding, stability, protein-protein

interactions, and cell-cell recognition.10 Changes in glycosylation are associated with

many diseases and play direct roles in pathological processes, including cancer metastasis,

diabetes, and inflammation.2,10-12 The efficacy of a number of biotherapeutics, such as
cytokines, hormones, Fc-fusion proteins, and monoclonal antibodies, are also deeply

affected by their glycosylation status.10,12
The importance of N-linked glycosylation has been becoming increasingly evident

over the years as many frequently used therapeutic proteins in the market, such as
Etanercept, Infliximab and Rituximab, are all N-glycosylated therapeutic proteins.10,12-14

N-linked glycans possess both intrinsic and extrinsic functions, where intrinsically, they

provide structural components to the cell wall and extracellular matrix; while extrinsically,

4

they direct the trafficking of glycoproteins and mediate cell signaling.10-12,15 Research

specifically concerning N-linked glycans can allow for further therapeutic advances and

provide greater insights that relate site-specific glycosylation to ligand or drug interactions.

1.1.2

Sialic Acids

Sialic acids are a family of neuraminic acid derivatives containing acidic

monosaccharides with a 9-carbon backbone. There are three main core structures of sialic
acids: Neu5Ac, Neu5Gc, and KDN. The most abundant sialic acid in human is Neu5Ac
(Figure 1.2A). The sialic acid family is further diversified by modifications on the core

structures with more than fifty distinct structures identified in nature, arising from
acetylation, methylation, lactylation, sulfation, and phosphorylation at the C-4, C-5, C-7,

C-8, or C-9 positions of the core structures.16 These modifications can occur on the same

core structure at multiple sites or with different combinations, and can determine or modify
their recognition by glycan-binding proteins and modulate sialic acid functions.16 Sialic

acids often terminate oligosaccharide structures of cell surface glycoconjugates, such as
branches of N-glycans, O-glycans, and glycosphingolipids, and are involved in many

biological recognition events.17,18 The linkage of sialic acids account for remarkable
diversity biologically. Different a linkages (Figure 1.2C) may be formed between the C-2

of sialic acid and underlying sugars by specific sialyltransferases, while the most common

linkages are to the C-3 or C-6 positions of galactose residues or to the C-6 position of Nacetylgalactosamine residues.17,18 Sialic acids can also occupy internal positions within

glycans with the most common being attachment of two sialic acid residues often at C-8
position.17,18 Internal sialic acid can occur in the repeating units of some bacterial

polysaccharides and echinodermal oligosaccharides.17,18

5

The very initial step in the viral life cycle is the attachment of the virus particle to the

cells surface. Sialic acids are highly conserved and are abundant in virtually all cells and
are generally present at the terminal reaches of cell surfaces, which causes them to be great

targets for viruses to adhere. Extrinsic sialic acid specific lectins are widespread in nature

on numerous pathogens to engage in many microbial-host interactions through the
recognition of specific sialylated ligands.18,19 Pathogens including adenoviruses,

rotaviruses and influenza viruses take great advantage of host-sialylated structures for
binding to gain access into target host cells for viral infections.20 Hemagglutinin activity
(HA) glycoproteins on influenza viruses allow sialic acid binding on both the surface of

human erythrocytes and on the cell membranes of the upper respiratory tract. Other
prominent examples include the binding of Helicobacter pylori to gastric mucins and

glycosphingolipids, and the interaction of cholera and tetanus toxins with target
gangliosides on mammalian cells.18 A large spectrum of other viruses has also been found

to use sialic acid as receptor via various degrees of specificity. For example, some
coronaviruses, namely from the Betacoronavirus genus, recognize O-acetylated sialic

acids, while some members from the alpha- and gammacoronaviruses genus prefer Nacetyl- or N-glycolylneuraminic acid.19 With sialic acid being the receptor determinant of

many pathogenic viruses, therapeutic interventions that compete with host sialic acid have

been of medical interest. For example, anti-influenza drugs such as oseltamivir and
zanamivir are sialic acid analogs that inhibit the viral enzyme neuraminidase, thus interfere

with release of newly generated viruses from infected cells.20

6

Figure 1.2. Structure, diversity, and linkage of SA. (A) Three major SAs in nature. (B)
Modifications on SAs. (C) Glycosidic linkages of SAs. (Cited from Ref 16.)
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1.1.3

Sialic Acid Recognition and Siglecs

Carbohydrate-binding proteins, collectively known as lectins, are highly specific
for different glycan moieties and glycosylation linkages. Siglecs are type I membrane

proteins that have an extracellular N-terminal and intracellular C-terminal domain. The N-

terminus consists of a V-type immunoglobular domain that is responsible for ligand
binding. The primary ligands of Siglec are sialic acid containing glycans.3 One major role

of Siglecs is their participation in the discrimination between self and non-self. This unique
attribute allows the regulation of cellular functions in the innate and adaptive immune

systems through glycan ligands recognition.21 There are many types of Siglec and humans
express a large set of CD33-related Siglecs, which include Siglec-3, Siglec-5, Siglec-6,

Siglec-7, Siglec-8, Siglec-9, Siglec-10, Siglec-11, Siglec-14 and Siglec-16. (Figure 1.3)

Each Siglec has preference for specific types of sialylated structures that are expressed on

cells and they have shown to be involved in the resolution of ongoing inflammation. For
example, Siglec-8 functions in resolving allergic inflammation, while Siglec-9 function in

resolving neutrophil-mediated inflammation.22-28 Siglec-9 is believed to play an important
part in the anti-inflammatory pathway by enhancing IL-10 production.26 The IL-10

enhancement capabilities are thought to be driven by the tyrosin residues in the cytoplasmic

tail of Siglec-9, because they can be abrogated if tyrosin is mutated into phenylalanine.26

The interactions of Siglecs with sialylated ligands play a key role in modulating
their activity as regulators of immune cell functions.3,21-25 Laubli et al.28 have recently
described the inhibitory effects of Siglec-9 engagement on human neutrophils and

macrophages with tumor-expressed sialic acid. Furthermore, another recent study
discovered that nanoparticle surface display of sialic acid promotes oligomerization and
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activation of Siglec-E on mouse macrophages, which are essentially a murine ortholog of

human Siglec-7 and Siglec-9.29 They exploited the effects of sialic acid-Siglec interactions
to elicit therapeutically usefulness in murine models of systemic and pulmonary
inflammation, where their findings validated that Siglecs are druggable anti-inflammatory

targets.29

Figure 1.3. Siglec-family proteins in humans and rodents. Cited from Ref. 30.
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1.2 Biomimetic Glycopolymers
Carbohydrate-protein interactions contribute to important biological functions and can

be applied using biomaterials in tissue engineering, drug delivery, biosensors, and

medicine, they are also important in terms of proteome analyses.31 These interactions are
amplified by the saccharide-assembly structure of glyco-clusters.31-34 Monomeric
saccharide interactions are considered weak, because they feature hydrogen bonding and

chelation with ions instead of stronger interactions such as hydrophobic and electrostatic

interactions.31

Lectins naturally have multiple carbohydrate-binding sites that can be taken advantage
of by incorporating a multivalent ligand delivery system.33,34 Glycopolymers, polymeric
structures that express pendant glycan units, can have the appropriate physical properties

and material workability to engage in strong interactions because of their high
multivalency.31,33,34 Multivalent ligands are favored not only because of their increased

target binding probabilities, but also the added diverse binding modes and possibilities
which contribute to gains in both enthalpy and entropy.31

Many approaches to construct and design glycopolymers have been employed over the

year since their inception in 1985.35 Prominent early works of glycopolymers involved
synthesis of poly(acrylic acid) derivatives expressing sialic acid moieties.36-38 The reported

strong multivalent binding properties of the sialylated glycopolymers to influenza viruses
showed notable inhiation of hemagglutination, which could suggest possible abrogation of
viral infection.36 These early work laid the foundations and highlighted the potential of

glycoplymer’s strong recognition abilities, as well as biocompatible functionalities,
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inspiring further efforts in research, design, and refinement in developing more feasible
synthetic approaches, rigid physical architecture, and practical biomedical applications.
Table 1. Synthesis of recent sialo-glycopolymers.
Polymerization
Backbone-type
N-Carboxyanhydride
Mucin-like
Polymerization
polypeptide
Atom-Transfer Radical
CholesterolPolymerization
terminated poly
(acrylic acid)

Sialylation
Enzymatic sialylation

Ref.
39

Copper-catalyzed
cycloaddition

40

Propargylated
thiosialosides grafted to
scaffold azides

Polymeric
Thiosialosides

Copper-catalyzed
cycloaddition

41

n-allyl nickel
Coordinating
Polymerization

Fluorescent labeled
end-functionalized
phenoxyl allene
backbone

Direct synthesis of
sialylated monomers

42

Dextran polysaccharide
template

Dextran

Copper-catalyzed
cycloaddition

43

Chemical synthesis of
trisialic acid

Polysialic acids

Chemical a-selective
O-sialylation

44

Oxime polymer initiated
by phospholipid

Methyl vinyl
polyketone backbone

Aminoxysialyllactose
conjugation to
backbone

45

Cyanoxyl-Mediated Free
Radical Polymerization

Chain-end
functionalized
polyacrylamide
backbone

Enzymatic sialylation

46

Polymerized chitosan

Chitosan backbone

Enzymatic sialylation

47

GM3 mimetic

Polyacrylamide
backbone

Enzymatic sialylation

48
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1.3 Synthesis of Sialo-glycopolymers
The main synthetic approaches employed in recent years to yield sialo-glycopolymers
divide into : (1) a convergent strategy, where acrylation of monomeric sialoside allows for

a free-radical polymerization to achieve a sialylated backbone assembly; and (2) a
divergent strategy, where enzymatic sialylation or catalyzed cycloaddition are applied to
couple monomeric sialoside onto established polymeric scaffolds.49 In a convergent

strategy, it is consensual that several challenges must be met to synthesize defined sialo
polymers, due to the innate negatively charged sialoside ligands and acid groups that may
lower the efficiency of a free-radical polymerization.49 Recently reported works have

mainly employed the divergent strategy, as they are typically suitable for polysaccharide
ligands and allows for large-scale synthesis of glycopolymers.49 In Delaveris et al’s work
reported in 2020, a synthetic sialylated glycocalyx was constructed by first synthesizing

glyco-polypeptides using N-Carboxyanhydride polymerization followed by enzymatic
sialylation.39 Similar enzymatic approaches to sialylate established scaffolds were also

employed by Li et al47 and Uemura et al,48 where, respectively, chitosan backbone was
sialylated by sialyltransferase47 and lactosylceramide was enzymatically sialylated to
produce GM3 mimetics.48 In the works reported by Wang et al,40 Brissonnet et al,41 and
Yamaguchi et al,43 copper-catalyzed azide-alkyne cycloaddition was employed to establish
sialo-poly(acrylic acid), polymeric thiosialosides, and sialo-dextran.

1.4 Structure of Sialo-glycopolymers
Sialo-glycopolymer structures vary substantially in their chemical architecture,

however, they are typically intrinsically biomimetic and biocompatible. For example,
Delaveris et al’s sialo-polypeptide structure mimics natural membrane-tethered mucin,
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which is a network of glycoproteins targeted by Influenza A virus to gain entry into host
cells.39 Similarly, in Yamaguchi et al’s work, dextran was employed as the polymeric
backbone due to its inherent compatibility under any biological conditions.43 In general,
the focus is to produce structurally well-defined glycopolymers that contain readily

accessible and biologically active oligosaccharides. Some reported structures aimed to
include additional functionalities. For example, Ohira et al investigated the use of n-allyl
nickel catalyzed coordination polymerization of allene monomers as an alternative method

for the synthesis of glycopolymers with azide at the polymer chain-end, which allows for

cycloaddition of a fluorescent dye containing acetylene.42 Zhang et al made a similar
approach where azide-alkyne cycloaddition was employed to incorporate Cy5 onto the

polysialic acid ligand.44
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Table 2. Structure and biomedical applications of recent sialo-glycopolymers.
Structure

Application

Delay fusion kinetics of Influenza A virus

14

Ref.

39

Structure

Application

Anticancer via surface engineering of NK-92

15

Ref.

40

Structure

16

Application

Ref.

Sialidase inhibition

41

Structure

Application

Ref.

Dissociation of

42

Siglec-7-GD3
..
N3

omo

17

interactions

Application

Structure

18

Ref.

Structure

Application

Ref.

Fluorescent

44

imaging of

receptors

o

19

Structure

Application

Ref.

Protection from

45

o.

o
Px
,0 OH

NK-mediated

Apoptosis

o

20

Structure

2,6 Sialyllactosyl

2,3 Sialyllactosyl

21

Application

Ref.

Evaluation of protein binding activities for

46

potential antiviral drug screening

22

Application

Ref.

Viral adhesion inhibition and decontamination

47

Structure

23

Application

Ref.

Inhibition of NIH3T3 fibroblast proliferation

48

1.5 Application of Sialo-glycopolymer
Sialo-glycopolymers are constructed primarily to exploit sialic acid’s vital role in
innate immune response. Synthetic sialo-polypeptides can act as a protective mechanism

against Influenza A virus, where viruses are drawn to decoy vesicles instead of mucosal
epithelial target cell, thus delaying viral fusion kinetics.39 Sialo-poly(acrylic acid) allows
for surface glycoengineering of NK-92 cells, which greatly enhancing their cytotoxicity
toward tumor cell expressing CD22.40 Polymeric thiosialosides promote pathogenic
sialidase binding with improved affinity. This anti-infective approach negates the effort of

virulence factors to remove sialo-glycan molecules of host cells.41 Fluorescent
functionalized sialo-polymers can target and modulate Siglec-7 by dissociating and

inhibiting its binding from ligands, while allowing fluorescence imaging of receptors.35-37
Additionally, sialo-glycopolymers can be employed in microarray fabrication and glycol

biosensor applications for efficient screening of protein binding specificity.46
1.6 Research Rationale
Targeting proteins with synthetic glycans have great potentials for both the

identification of specificity and induction of immunomodulation that can lead to desired
immune responses. Achieving carbohydrate-protein recognition by multivalently targeting

lectin receptors can be exploited by displaying multiple sugars on the backbone of a

polymer to mimic the glycan presentation in natural glycoconjugates. Glycopolymers have

been shown time and time again to be very attractive multivalent carbohydrates which
possess useful immune cell targeting potentials. They can be remarkably applicable with
high affinity or selectivity if constructed from rational design and practical synthesis.
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In recent years, there have not been many significant advancements toward a well-

rounded investigation of synthetic glycan’s functional- and bio-capabilities. This
dissertation documents key research to tackle the problem of synthesizing versatile
biomimetic glycopolymers that are readily effective both chemically and biologically

across areas including glycan recognition, nanomaterial wrapping, and immune targeting.
A. Aryl Azide Chain-End Functionalized N-Linked Glycan Polymers as Photo-

Activatable Probes for Protein Specificities
In the past, multivalent glycopolymer scaffolds incorporated with photo-activatable

crosslinkers was explored for elucidating the interactions of proteins with a wide variety
of ligands50. Aryl azide is one of the most often-used photo-crosslinkers that generates
highly reactive species upon photo-irradiation and reacts with adjacent molecules, resulting
in a direct covalent modification. Reported glycopolymers by Wibow et al. were designed
with both glycans and photoactivatable crosslinkers pending on the polymer backbone50,

which has substantial pitfalls in both accessibility to the target and efficiency of the
crosslinking due to hinderances from each unit. For practicality, my reported design of the
photo-crosslinkable multivalent N-glycan polymers employs the incorporation of a photo-

activatable crosslinker at the polymer chain end, which can facilitates direct site-specific
and oriented immobilization51. This molecular recognition pattern can be especially useful

on surfaces for the development of biosensors, chip-based bioassays, and cell adhesion

studies as they closely mimic the three-dimensional display of glycans on the cell
surface46,51. In this work, I proposed a straightforward synthesis of aryl azide chain-end

functionalized N-linked glycan polymers to act as photoactivatable multivalent glyco
ligands for specific protein labeling and functionality study.
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B. Carbohydrate and Chain Length Controlled Complexation of Carbon Nanotubes
by N-Glycan Polymers
Single-wall carbon nanotubes (SWCNTs) have gained tremendous attention for

both material and biomedical research and applications.52-54 Particularly, semiconducting
SWCNT species have well-defined electronic structures and optical properties, as well as

fluoresce in the near-infrared (NIR) region, an important spectral region where attenuated
tissue autofluorescence and deep tissue penetration occur in biological samples.55,56

However, obtaining effective dispersions of individual SWCNTs in aqueous environments

has been a major challenge given that it is the prerequisite for their processing and specific

applications in vivo. During the past decades, different ways and means, including covalent
and noncovalent methods, have been explored for dispersing SWCNTs in water. Covalent

modification of SWCNTs often causes permanent changes in the carbon lattice from sp2 to
sp3 orbital hybridization that may result in optical, electrical, and mechanical

deterioration.57,58 Noncovalent wrapping with surfactants, peptides, and polymers has been
found to be a simple way of stabilizing SWCNTs in water.59-61 The wrapping of SWCNTs

by polymers driven by the synergy of many interactions, such as van der Waals attractions,
multivalent n-n stacking, and hydrophobic interactions, presumably enhance the aqueous

solubility of SWCNTs without disrupting the n-system of the tube. Some conjugated

polymers showed significantly higher energy of interaction with nanotubes compared to
that of small molecules, leading to better solubilization of SWCNTs in solvents.60
Furthermore, creating water-soluble polymer-wrapped SWCNT complexes utilizing

biocompatible, biomimetic, and biological active polymers will provide vast potentials in

biological and biomedical research and application. In this work, I proposed a small library
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of the precisely synthesized novel aryl azide chain-end functionalized N-glycan polymers
with varying carbohydrate density and chain length to demonstrate their ability in

stabilizing SWCNTs via noncovalent complexation in aqueous conditions.

C. Evaluation of the Immunomodulation Effects of N-Glycan Polymers on Mouse
Macrophage using Newly Developed High-Throughput Multiplex Assays
According to vast evidence suggesting that the interactions between Siglecs

expressed on the immune cell surfaces and sialylated ligands can constitute for key
modulating activities and regulatory functions,3,21-25,28,29 the novel N-glycan sialylglycopolymers could be great immunomodulating molecules of choice to be tested on

immune cell targets. It is challenging to rapidly identify immune responses that reflect the

state and capability of immune cells due to complex heterogeneity of immune cells and
their plasticity to pathogens and modulating molecules.62 Thus, high-throughput and easy-

to-use cell culture and analysis platforms are highly desired for characterizing complex

immune responses and elucidating their underlying mechanisms.63,64 In this work, I
proposed the development of a micropillar chip and a 384-pillar plate, printed mouse
macrophage, RAW 264.7 cell line in alginate on the pillar plate platforms, and the

establishment of multiplex cell-based assays to rapidly measure cell viability, expression

of cell surface markers, and secretion of cytokines upon stimulation first with model
compound, lipopolysaccharide (LPS), then with synthetic novel N-glycan polymers to
investigate their unique immunomodulation effects.

27

CHAPTER II
ARYL AZIDE CHAIN-END FUNCTIONALIZED N-LINKED GLYCAN

POLYMERS AS PHOTO-ACTIVATABLE PROBES FOR PROTEIN

SPECIFICITIES

2.1 Introduction
Cell

surface

carbohydrates,

existing as

glycoproteins,

glycolipids,

and

proteoglycans, often serve as receptors and relay critical interaction and trigger crucial
signaling events in many biological processes, such as cell-cell interaction, pathogen/host

interactions, tumor metastasis, immune response, and many more2. Glycoscience research

specifically concerning the carbohydrate-protein interactions can provide an abundant
opportunity to discover molecular mechanisms of biological processes, potential
therapeutic targets, and diagnostic mechanisms for various diseases2. Therefore, sensitive
profiling of carbohydrate-protein interactions is the initial and key step for basic research,
clinical diagnostics, and therapeutic applications. In fact, the diversity and complexity of

glycan structures, together with their crucial roles in many physiological or pathological
processes, require the development of effective tools for the comprehensive analysis of
carbohydrate-protein interactions.65
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Various analytical techniques have been developed to study specific carbohydrate-

protein interactions, including affinity chromatography, affinity-based probes and active
based probes65. Affinity photo-crosslinking has become one of the most powerful strategies
to study carbohydrate-protein interactions66. Upon photo-irradiation, a photo-crosslinking
functional group generates highly reactive species that react with adjacent molecules,

resulting in direct covalent modifications, which can be used for target imaging, isolation,

and identification applications. The common photo-crosslinking groups used in affinity

based probes are aryl azides, benzophenones and diazirines66.
Staightfoward Synthesis

Photo-crosslinking

Crosslinking

Figure 2.1. Aryl azide chain-end functionalized glycopolymer for specific protein photo
labelling.
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2.1.1 Cyanoxyl Mediated Free Radical Polymerizations
Among a wide range of polymerization techniques67, CMFRP is a straightforward
approach to synthesize chain-end functionalized glycopolymers using functionalized aryl

amine as initiators9,67-69. In essence, CMFRP of unprotected glycomonomers can be
conducted in aqueous solution, which is tolerant of a broad range of functional groups

including COOH, NH2, OH and SO3- moieties, and can yield glycopolymers with low

polydispersity (PDI < 1.5). To achieve glycopolymers with a photo-labeling functionality,
an aryl azide initiator can be employed as the initiator for polymerization with the mixture

of acrylated glycomonomer and acrylamide67,69. Glycosylamines are first prepared as the
key intermediates for the eventual synthesis of N-linked glycan polymers. The Kochetkov

direct method was utilized to form glycosylamines from free glycans as previously
reported9,70,71.
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n3

NaNO2, HBF4
H2O-THF (1:1), 0°C
NH2----------------------- * N3

N+—N BF4-

r2 1a-1c
NH4HCO3
nh3-h2o

NaOCN/H2O-THF (1:1), 50°C

H2O-THF (1:1), 50°C

Scheme 1. Straightforward synthesis of N-linked glycan polymers (4) from free glycans
(1) via glycosylamine intermediates (2) followed by acrylation (3) and Cyanoxyl Free
Radical-Mediated Polymerization (CMFRP).

Free glycan was treated with ammonium bicarbonate in ammonium oxide to
generate glycosylamines quantitatively9,70, then the N-acryloyl group was introduced by

treatment with acryloyl chloride in methanol-water while in the presence of sodium
carbonate at 0°C, followed by the removal of excess acryloyl chloride and sodium
carbonate to yield N-acryloyl-glycosylamines as glycomonomers. Next, 4-azidoanaline

was used as aryl azide initiators for N-linked glycan polymer synthesis via CMFRP scheme
in one-pot fashion. Initially, cyanoxyl radicals were generated by an electron-transfer
reaction between cyanate anions from a sodium cyanate aqueous solution and aryl

diazonium salts were prepared in situ through a diazotization reaction of aryl amine in
31

water. In addition to cyanoxyl persistent radicals, aryl-type active radicals were

simultaneously produced, and only the latter species was capable of initiating chain growth.

Overall, aryl azide chain-end functionalized N-glucosyl polymer, N-galactosyl polymer,
and N-lactosyl polymer were synthesized in very good yields (over 60%).

2.1.2 Aryl Azide Chain-end Functionalization
To make targeting and studying of carbohydrate-protein interactions more

manageable and facilitate the proteome-wide identification of various carbohydrate-protein
interactions, multifunctional glyco-ligands with other functional groups, such as labeling

and probing units, are much desired50,66,72. In the past, multivalent glycopolymer scaffolds

incorporated with photo-activatable crosslinkers was explored for elucidating the
interactions of proteins with a wide variety of ligands50. Aryl azide is one of the often-used

photo-crosslinkers, which generates highly reactive species upon photo-irradiation and

reacts with adjacent molecules, resulting in a direct covalent modification. Specifically,
when an aryl azide is activated by UV photons, which occurs with long wavelength UV

light (330-370 nm), a nitrene group is formed and able to create reactive carbene
intermediates that can react with neighboring C-H and heteroatom-H bonds, forming a

new covalently bonded product15,73. In addition, aryl azide is chemically stable and has

superior photophysical properties. Reported glycopolymers were designed with both

glycans and photoactivatable crosslinkers pending on the polymer backbone50, which has
substantial problems of both accessibility to the target and efficiency of the crosslinking

due to hinderances from each unit. For practicality, this design of the photo-crosslinkable
multivalent N-glycan polymers employs the incorporation of a photo-activatable

crosslinker at the polymer chain end. In recent years, chain-end groups have been
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demonstrated to render glycopolymers with potential utility in bio- and immunochemical
assays as bio-capture reagents, as well as for microarray applications, due to their
allowance for a direct one-to-one attachment that facilitates site-specific and oriented

immobilization67. This molecular recognition pattern can be especially useful on surfaces

for the development of biosensors, chip-based bioassays, and cell adhesion studies as they

closely mimic the three-dimensional display of glycans on the cell surface67,68.
In this work, aryl azide chain-end functionalized N-linked glycan polymers were

used as photoactivatable multivalent glyco-ligands for specific protein labeling and

functionality study. Here demonstrates a straightforward synthesis of aryl azide chain-end
functionalized N-linked glycan polymers from free glycans via glycosylamine

intermediates followed by acrylation and polymerization via cyanoxyl-mediated free
radical polymerization (CMFRP) in one-pot fashion. Affinity-assisted photo-labeling

capabilities of the aryl azide N-linked glycan polymer was demonstrated with aryl azide Nlactosyl polymer as a ligand for ^-galactose-specific lectin from Arachis hypogaea (peanut
agglutinin, PNA) after UV irradiation followed by SDS-PAGE with silver staining.

2.2 Experimental
2.2.1

Materials and Methods
All solvents and reagents were purchased from commercial sources and were used

as received. Dialysis was performed using dialysis tubing. PNA and ConA were obtained

from Sigma. Glc, Gal, and Lac were purchased from Sigma (USA). Deionized water with

a resistivity of 18 MQ cm-1 was used as solvent in all polymerization reactions and dialysis
experiments. Dialysis was performed using cellulose membrane with a molecular weight
cutoff of 3 kDa with water as solvent. 1H NMR spectra were measured at room temperature

33

with a Bruker AV400 MHz spectrometer and D2O was used as deuterated solvent. FT-IR

spectrum was obtained using Spectrum TwoTM from PerkinElmer.
2.2.2

Synthesis of Acrylamide Glycomonomers

Glycosylamines were first prepared via the Kochetkov method9. A solution of
saccharide (5.0 mmol) and ammonium bicarbonate (389.0 mg, 5.0 mmol) in 20 mL of

aqueous ammonia was kept in an oil bath at 40°C for 40 h and then was freeze-dried to

afford glycosylamines, which were directly subjected to the next reaction without
purification.

Acrylation of glycosylamines was accomplished by first drying the glycosylamines

obtained above, then dissolved in 60 mL of CH3OH-H2O (1:1, v/v) and 3.0 g of Na2CO3

was added, respectively. The mixture was cooled in an ice bath for 30 min and then a
solution of 1.28 mL of acryloyl chloride in 7 mL of THF was added dropwise. After that,

the reaction mixture was stirred at 0°C for another 1 h. The organic solvents were

evaporated under reduced pressure and the remaining aqueous layer was lyophilized to

dryness, which were purified by silica gel column chromatography eluted with EtOAc and
CH3OH (5:3, v/v) afford glycomonomers.
2.2.3

Synthesis of Aryl Azide Chain-end Functionalized N-glucosyl Polymer and
N-galactosyl Polymer

4-Azidoaniline (3.1 mg, 0.018 mmol) and 6.4 uL of HBF4 solution (48 wt%, 0.054

mmol) were dissolved in 200 |iL of degassed ddH?O in a three-necked flask. The mixture
solution was cooled in an ice bath for 30 min and a solution of sodium nitrite (NaNO2, 2.8
mg, 0.034 mmol) in 200 |iL of ddH2O was added to react for 30 min in an atmosphere of
N2. Then, a degassed mixture solution of N-(prop-2-enoyl)-P-D-glucopyranosylamine
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(42.0 mg, 0.18 mmol) or N-(prop-2-enoyl)-p-D-galactopyranosylamine (42.0 mg, 0.18

mmol), acrylamide (51.2 mg, 0.72 mmol) and NaOCN (1.2 mg, 0.018 mmol) dissolved in

1 mL of degassed ddH2O was added into the flask containing the diazonium salt. The

reaction solution was kept in an oil bath at 60°C to react for 20 h. The resulting mixture

was dialyzed against ddH2O for 2 days to remove the impurity and then freeze-dried to
yield the N-glucosyl polymer (72.0 mg, 58.0%) or N-galactosyl polymer (82.0 mg, 78.0%).

The molecular weight (Mn) of N-glucosyl polymer was about 33,300 with saccharide

content at about 9,000 as determined by 1H NMR spectrum. The molecular weight (Mn)

of N-galactosyl polymer was about 21,800 with saccharide content at about 9,000 as
determined by 1H NMR spectrum.

2.2.4

Synthesis of Aryl Azide Chain-end Functionalized N-Lactosyl Polymer

4-Azidoaniline (12 mg, 0.07 mmol) and sodium nitrite (NaNO2, 10 mg 0.14 mmol)
were dissolved in 2.5 mL of H2O-THF (1:1) in a three-necked flask. The mixture solution

was cooled in an ice bath for 30 min and the 36 uL of HBF4 solution (48 wt%, 0.276 mmol)
was added to react for 1 h. Then, a degassed mixture of N-(prop-2-enoyl)-p-Dlactopyranosylamine (420 mg, 1.06 mmol) acrylamide (280 mg, 3.94 mmol) and NaOCN

(10 mg, 0.153 mmol) dissolved in 2 mL of ddH2O was added into the flask containing the
diazonium salt. The reaction solution was kept in an oil bath at 60°C to react for 20 h. The

resulting mixture was dialyzed against ddH2O for 2 days to remove the impurity and then
freeze-dried to yield the glycopolymer (436 mg, 62.3%). The molecular weight (Mn) was
about 78,970 with saccharide content at about 19,500 as determined by 1H NMR spectrum.

35

2.2.5

Synthesis of Aryl Azide Chain-end Functionalized Polyacrylamide

Preparation of aryl azide chain-end functionalized polyacrylamide. 4-Azidoaniline

(7.2 mg, 0.042 mmol) and sodium nitrite (NaNO2, 6 mg 0.084 mmol) were dissolved in
1.5 mL of H2O-THF (1:1) in a three-necked flask. The mixture solution was cooled in an

ice bath for 30 min and the 21.6 uL of HBF4 solution (48 wt%, 0.166 mmol) was added to

react for 1 h. Then a degassed solution of acrylamide (420 mg, 5.91 mmol) and NaOCN (6
mg, 0.0918 mmol) dissolved in 1.2 mL of ddH2O was added into the flask containing the

diazonium salt. The reaction solution was kept in an oil bath at 60°C to react for 20 h. The
resulting mixture was dialyzed against ddH2O for 2 days to remove the impurity and then

freeze-dried to yield the aryl azide chain-end functionalized polyacrylamide (350 mg,

83.4%). The molecular weight (Mn) was about 44,744 as determined by 1H NMR spectrum
2.2.6

UV-induced Photo-crosslinking Assay

Glycopolymers (2.8 mg, 3.57 x 10-8 mol) and lectin Arachis hypogae (0.6 mg,
5.45x10-9 mol, lyophilized powder, Sigma) were dissolved in 100 uL of PBS buffer (pH
7.4) solution containing 0.2% Tween 20 and allowed to react for 4 h in RT. Then, the

mixture was degassed and exposed to a 366 nm UV source in the dark for 30 min while

remaining on ice.
2.2.7

SDS-PAGE

Laemmli Sample Buffer (Bio-Rad, #1610737) was prepared according to product

guidelines. Sample taken directly from photo-crosslinking assay was added to Laemmli

Sample Buffer toproduce aliquots corresponding to 25 ug of protein (5 uL) for each sample
and then boiled at 100°C for 20 min. Samples were then characterized in SDS-

polyacrylamide gels containing 10% diH2O, 12% acrylamide/Bis-acrylamide, 25% 1.5 M
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Tris-HCL pH 8.8, 0.1% SDS, 0.1% APS, 0.1% TEMED, and electrophoresis were
performed at 120V for 90 min followed by silver staining (Pierce® Silver Stain Kit,

Thermo Scientific).

2.3 Results and Discussion
2.3.1

Polymer Structure and Saccharide Density Determined by 1H NMR Spectra

The progress of N-glycan polymer synthesis was monitored by 1H NMR spectra.

For N-lactosyl polymer, the successful amination of free lactose was confirmed by the

signals of anomeric proton directly adjacent to the introduced amine (4.05 ppm), while the
introduction of acrylamide was confirmed by the signals of protons on the alkene (5.82 and

6.25 ppm) as well as the downfield signal shift of the anomeric proton directly adjacent to
amine (5.05 ppm). The saccharide density and average molecular weight of the resultant

glycopolymers were also determined by 1H NMR spectrum.
For N-lactosyl polymer, the integration of protons on the terminal phenyl group
(7.1 and 6.9 ppm), sugar anomeric carbons (4.4 and 4.9 ppm), sugar backbones (3.40 to

3.80 ppm) and polymer backbones (2.10 to 2.30 ppm and 1.80 to 1.30 ppm) were assigned
and calculated for its saccharide density of 57 and an average molecular weight of 78,970

Mn.

2.3.2

FT-IR Spectrum Revelation of Chain-end Functional Groups
The chain-end azido and O-cyanate functional groups of the glycopolymers were

confirmed by FT-IR spectrum, in which azide absorption was observed at 2118.6 cm-1
while O-cyanate absorption was observed at 2217.6 cm-1. In comparison, aryl chloride

chain-end functionalized N-lactosyl polymer synthesized in our previous report showed
only O-cyanate absorption at 2217.6 cm-1.
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Figure 2.2. 1H NMR spectrum of P-lactose (D2O, 400 MHz NMR).
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Figure 2.3. 1H NMR spectrum of P-d-lactopyranosylamine (D2O, 400 MHz NMR).
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Figure 2.4. 1H NMR spectrum of N-(prop-2-enoyl)-P-d-lactopyranosylamme (D2O, 400
MHz NMR).
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Figure 2.5. 1H NMR spectrum of p-azido-phenyl-P-d-Gal(1-4)-P-d-Glc- N-glycopolymer
(D2O, 400 MHz NMR).
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Figure 2.6. FT-IR spectrum of p-Cl-phenyl-P-d-Gal(1-4)-P-d-Glc-N-glycopolymer (A)
and p-azido-phenyl-P-d-Gal(1-4)-P-d-Glc- N-glycopolymer (B).

2.3.3

SDS-PAGE Characterization of Crosslinking Activity

Photo-labelling of specific proteins was evaluated with the aryl azide chain-end N-

lactosyl polymer as ligand for the GalP-1,4-Glc-specific Arachis hypogaea (PNA). As
controls, aryl azide chain-end acrylamide polymer, aryl azide chain-end N-glucosyl
polymer and aryl azide chain-end N-galactosyl polymer were tested with PNA in the same

manner, respectively.
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Figure 2.7. (A) SDS-PAGE characterization of glycopolymer-PNA crosslinking after UV
irradiation. Lane M. MW marker; lane 1. Arachis hypogaea (PNA) only (negative control);
lane 2. PNA + N3-AM polymer; lane 3. PNA + N3-Glc polymer; lane 4. PNA + N3-Gal
polymer; lane 5. PNA + N3-Lac polymer. Silver staining, polymer/protein molar ratio: 6:1.
(B) SDS-PAGE characterization of glycopolymer-ConA crosslinking after UV irradiation:
lane M. MW marker; lane 1. ConA only (negative control); lane 2. ConA + N3-Glc
polymer; lane 3. ConA + N3-Lac polymer. 50 ng of protein loaded in each lane. Silver
staining.

2.3.3.1 Probing of Arachis hypogaea (PNA) using N-lactosyl Polymer

PNA is a homotetrameric protein with specificity for P-O-Gal such as Gaip-1,4-Glc

in P-lactose, which in theory should display affinity only for the N-lactosyl polymer, but
not acrylamide polymer, N-glucosyl polymer and N-galactosyl polymer. Only N-lactosyl

polymer-PNA affinity-assisted photo-labeled complexes exhibited a definitive darkened

smear staining, which confirmed the formation of supramolecules via specific binding and
photo-crosslinking. Like the N-lactosyl polymer, the other polymers all possessed the aryl

azide chain-end groups but did not have P-O-Gal necessary for PNA affinity, which
showed no noteworthy photo-crosslinking.
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Observations can be made that slight smearing exhibited in all lanes except for the
negative control where only PNA was present, suggesting the expected functionality of the

aryl azide groups, which may crosslink with proteins when they are close enough due to
non-specific bindings. The SDS-PAGE results also indicated that it was, for the most part,
unnecessary to wash away unbound glycopolymers before UV irradiation, as

glycopolymers without assistance of protein affinity displayed drastically lower degree of
supramolecule formation following photo-induced crosslinking, suggesting that specific
affinity played a vital role in establishing proximity between the aryl azide functional

groups and the amino acids of the proteins, where crosslinking and covalent bonding would
take place. Compared to the single band of unlabeled protein, the smear staining of the
photo-labeled proteins indicated variously sized supramolecular formation due to multiple

glycopolymers cross-linking to each lectin unit of homotetrameric PNA74 via the single
aryl (azide) chain-end. Specifically, some lectin molecules have more glycopolymers

conjugated while others have fewer glycopolymers conjugated, all together generating a
mixture of lectin-glycopolymer conjugates as smear bands in SDS-PAGE. This

phenomenon is often seen in protein-glycopolymer SDS-PAGE characterizations75-77.
2.3.3.2 Probing of Concanavalin (ConA) using N-glucosyl Polymer
A photocrosslinking experiment with aryl azide chain-end functionalized N-glycan

polymers and ConA lectin, which specifically binds to a-Glc and a-Man78, was conducted.
As a result, aryl azide chain-end functionalized N-lactosyl polymer did not achieve any

photo-crosslinking with ConA lectin, while aryl azide chain-end functionalized N-glucosyl
polymer showed specific photo-crosslinking with ConA lectin. This result further
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confirmed the specific photocrosslinking capacity of the aryl azide chain-end
functionalized N-lactosyl polymer for the target lectin PNA.
(lane 5)

(lane 4)

Lane 3

Lane 4

Lane 5

Figure 2.8. SDS-PAGE characterization of glycopolymer-protein crosslinking in
controlled conditions after UV irradiation: lane M. MW marker; lane 1. N3-Lac polymer +
free P-lactose + PNA (competitive); lane 2. PNA + free P-lactose + N3-Lac polymer
(sequential); lane 3. N3-Lac polymer + PNA (1 : 1 molar ratio); lane 4. N3-Lac polymer +
PNA (3 : 1 molar ratio); lane 5. N3-Lac polymer + PNA (6 : 1 molar ratio).
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250 kDa150 kDa100 kDa-

75 kDa-

50 kDa-

35 kDa-

25 kDaFigure 2.9. SDS-PAGE characterization of comparative glycopolymer-protein
crosslinking after UV irradiation: lane M. MW marker lane 1. Cl-Lac polymer + PNA; lane
2. N3-Lac polymer + PNA. Silver staining. Polymer/protein molar ratio: 6:1.

2.3.3.3 Further Investigation into Polymer-Protein Photocrosslinking Mechanics

2.3.3.3.1 Ligand Competition
Selected control conditions focusing on competitivity and concentration were

performed. Free P-lactose disaccharide was introduced to PNA either competitively
alongside N-lactosyl polymer or sequentially prior to the introduction of N-lactosyl

polymer followed by UV irradiation. Both conditions displayed smears in a similar manner
(Figure 2.8, lane 1 and 2) and intensity as determined using ImageJ with the former

possibly being slightly more intense than the latter. This observation can contribute to the
consensus that the multivalent nature of carbohydrates presented on polymer backbones is
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much more preferred by lectins as multivalent ligands compared to monosaccharide single
unit ligands.
2.3.3.3.2 Ligand-Target Molar Ratio

A gradient can be achieved in the intensity of the smears when the reaction molar ratio
between N-lactosyl polymer and PNA is manipulated. As a result, when the molar ratio
between N-lactosyl polymer and PNA are equal, fewer supramolecules were formed

following affinity-assisted photo-labelling (Figure 2.8, lane 3), however, proportionally
more supramolecules were formed when more N-lactosyl polymer was used as observed
using ImageJ measurements (Figure 2.8, lane 4 and 5). Roughly, 20% increase was

measured in smear staining intensity when the molar ratio of N-lactosyl polymer to PNA

was increased from 1:1 to 6:1 (Figure 2.8 (lane 5)), which is coherent with a 20% decrease
measured in band intensity in respective lanes (Figure 2.8 (lane 4)). These results suggest

that the level of crosslinking is directly correlated to the molar ratio between the ligand and

protein, indicating the existence of a specific interaction between N-lactosyl polymer and
PNA.

2.3.3.3.3 Confirmation of Aryl Azide’s Participation in Photocrosslinking
To investigate the specific reactivity of aryl azide of the N-lactosyl polymer for

PNA labeling, aryl chloride chain-end functionalized N-lactosyl polymer synthesized in
our previous report was investigated for the same photo-crosslinking procedure for aryl

azide N-lactosyl polymer with PNA. As a result, aryl chloride chain-end functionalized Nlactosyl polymer did not achieve any photo-crosslinking with PNA compared with aryl
azide of the N-lactosyl polymer, which showed apparent PNA labelling. This observation
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confirmed that the chain-end aryl azide generates highly reactive species that reacts with

adjacent molecules, resulting in the direct covalent modification of proteins.

2.4 Conclusion

Aryl azide chain-end functionalized N-linked glycan polymers were developed as
photoactivatable glyco-ligands and their application for affinity-assisted photo-labelling of
the specific protein was characterized. CMFRP is a capable and attractive method for the
synthesis of chain-end functionalized N-linked glycan polymers, as it possesses several

advantages, such as direct polymerization, reaction in aqueous solution, exclusion of

tedious protection and deprotection steps, and compatibility with a broad range of
functional groups. The present synthetic method can be applied to synthesizing polymers

with any kind of glycan and alternative chain-end functionalizable groups, such as

benzophenone and diazirine. On the other hand, the reported aryl azide chain-end
functionalized N-linked glycan polymers have demonstrated undeniable capabilities for

specifically labelling proteins and will be useful multivalent ligands for specific protein

labelling and functionality study both in vitro and in vivo. In addition, the present polymers
can undergo further modification to its O-cyanate chain-end group to yield an additional

chain-end functional group, such as a biotin or fluorophore, thus achieving dual

functionalities on both ends of the polymers for protein imaging and proteomics
applications.
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CHAPTER III

CARBOHYDRATE AND CHAIN LENGTH CONTROLLED COMPLEXATION
OF CARBON NANOTUBES BY N-GLYCAN POLYMERS

3.1

Introduction

3.1.1

Single Walled Carbon Nanotubes

Carbon nanotubes are rolled up sheets of graphene in cylindrical form. They can be
divided into single well or multiple wells. Nanotubes with single well are described as
single-wall carbon nanotubes (SWCNTs) and were first reported in 199379. SWCNTs have

gained wide attention for both material and biomedical research and applications, such as
bioimaging,

biosensor,

and

drug

delivery

applications52-54,80-84.

Particularly,

semiconducting SWCNT species have well-defined electronic structures and optical
properties, as well as fluorescence in the near-infrared (NIR) region, an important spectral

regime where attenuated tissue autofluorescence and deep tissue penetration occur in

biological samples54-56.
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Figure 3.1. Semiconducting Single-Wall CNT Enriched in Chirality (6,5). (CHASMTM,
https://www.chasmtek.com/single-wall-cnts )
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Figure 3.2. Carbon nanotubes in biomedical applications. Cited from Ref. 84.

3.1.2

Aqueous Dispersion of SWCNT

Obtaining effective dispersions of individual SWCNTs in aqueous environments
has been a major challenge given that it is the prerequisite for their processing and specific
applications in vivo. During the past decades, different ways and means, including covalent
and noncovalent methods, have been explored for dispersing SWCNTs in water. Covalent
modification of SWCNTs often causes permanent changes in the carbon lattice from sp2 to

sp3 orbital hybridization that may result in optical, electrical, and mechanical

deterioration57,58. Noncovalent wrapping with surfactants, peptides, and polymers has been

found to be a simple way of stabilizing SWCNTs in water53,55,59-61,85,86.

The wrapping of SWCNTs by polymers driven by the synergy of many interactions,
such as van der Waals attractions, multivalent n-n stacking, and hydrophobic interactions,
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presumably enhance the aqueous solubility of SWCNTs without disrupting the n-system

of the tube. Some conjugated polymers showed significantly higher energy of interaction
with nanotubes compared to that of small molecules, leading to better solubilization of
SWCNTs in solvents60. Furthermore, creating water-soluble polymer wrapped SWCNT
utilizing biocompatible, biomimetic, and biologically active glycopolymers will provide

vast potentials in biomedical research and application.

3.1.3

Wrapping Mechanism of Polymers on SWCNT

The basis for the wrapping mechanism of polymers on the surface of SWCNTs via
noncovalent complexation in liquid media has been the subject of many studies. The

formation of a well-ordered DNA structure wrapped around SWCNTs has been

demonstrated extensively by both computational87-89 and experimental works, leading to
comprehensive carbon nanotube sorting90-92, and developing novel optical sensors of

biomolecules52,93-95.
Molecular dynamics simulations of natural polysaccharides, such as chitosan and

amylose chains, and SWCNTs in aqueous environments revealed the encapsulation of

nanotubes via the helical wrapping conformation96,97. Experimental work on imaging of
SWCNTs complexed with polysaccharides also suggested a helical coating pattern61,98.

The helical wrapping of SWCNTs has been accounted for many interactions including van
der Waals attraction and hydrophobic interactions between polysaccharides and SWCNTs,

as well as possible hydrogen bonding in carbohydrates that stabilizes the helical motif.

Aqueous dispersions of polysaccharide-SWCNT complexes are further stabilized because
of the hydrophilic hydroxyl groups of carbohydrates being exposed to water96,97.
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Figure 3.3. Glycopolymers and Glyco-SWCNT complexes. (a) Chemical structures of glycopolymers with monosaccharides and
disaccharides. (b) Photographs of bulk dispersions without centrifugation and supernatants collected after centrifugation of SWCNT
samples tip sonicated in Glc and Lact-copolymers. (c) Helical wrapping of a SWCNT by Lact-copolymers.
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3.1.4

Complexation of SWCNT with Glycopolymers
Glycopolymers, namely, polymers with carbohydrate pendant groups, have been

extensively used as glycoconjugate mimetics for different biological applications7,9,99. It is

generally accepted that synthetic glycopolymers can mimic the functions of naturally
occurring glycoconjugates100,101 and have been employed for biosensor and drug delivery

applications and biofunctionalization of nanomaterials of different interests100,102.

Noncovalent complexation of SWCNTs by glycopolymers is of interest because of the
potential of polymer backbone to form a wrapping structure on the nanotube surface, while

hydrophilic groups are exposed to water for entropic stabilization of polymer-SWCNT
complexes.

Synthetic glycopolymers also provide greater structural tunability compared to

natural glycoconjugates. Therefore, glycopolymers are of choice for producing stable
aqueous dispersions of SWCNTs. However, the interplay of both the carbohydrate pendant

groups and polymer chain length on creating stable carbohydrate coated SWCNT
complexes in aqueous environments has not been explored previously.

Herein, a systematic design of glycopolymers of various chain lengths having
different sugars for stable aqueous dispersions of SWCNTs was developed. Specifically,
the same polymer scaffold [i.e., polyacrylamide (PAM) backbone] was functionalized with

monosaccharide and disaccharide groups to produce a total of 14 glycopolymers with

different carbohydrate ligand densities and polymer chain lengths. It was concluded that

carbohydrate ligand density and polymer chain length play a synergistic role in interactions
with SWCNTs and creating stable glycopolymer-wrapped SWCNT complexes in water
that incorporate the NIR fluorescence of nanotubes and the unique carbohydrate
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functionality of glycopolymers. Additionally, the distinct complexation of glycopolymers
and

SWCNTs

examined

was

by

monitoring

the

optical

modulation

of

glycopolymer-SWCNT complexes upon interacting with surfactants and single-stranded

DNA. These findings provide important insights into creating stable, water-soluble
SWCNT complexes with carbohydrate functionalities that can be potentially utilized as

fluorescent

probes

in

biological

applications,

such

as

profiling

specific

carbohydrate-protein interactions.

3.2

Experiments

3.2.1

Materials and Methods

3.2.1.1 Carbohydrate and Chain Length Controlled Synthesis

All solvents and reagents were purchased from Sigma-Aldrich (USA) and were
used as received. Deionized (DI) water with a resistivity of 18 MQ cm was used as the

solvent in all reactions and dialysis experiments.
Biomimetic glycopolymers with monosaccharide and disaccharide groups were
synthesized via the cyanoxyl-free-radical-mediated polymerization scheme in one-pot

fashion, as previously reported9,99. In essence, cyanoxyl radicals were generated by an
electron-transfer reaction between cyanate anions from a sodium cyanate aqueous solution
and aryl-diazonium salts, which were prepared in situ through a diazotization reaction of

arylamine in water. Cyanoxyl persistent radicals and aryl-type active radicals were

simultaneously produced, where only the latter species was capable of initiating chain
growth,

thus

facilitating

the

copolymerization

of

N-acryloyl-glycosylamine

glycomonomers (Glyco-AM) and free acrylamide (AM). Particularly, glycocopolymers
(i.e., AM/Glyco-AM) expressing different densities of carbohydrate ligands (i.e., y/x) were
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synthesized by varying the ratios between N-acryloyl-glycosylamine glycomonomers and
free AM. Lact-homopolymers of various chain lengths n were synthesized by varying the

number of N-lactosylacrylamide monomers without inclusion of free AM. The oxidation

of homopolymer Lact-AM 53 was performed by dissolving 10 mg of polymers in a total
volume of 1 mL solution of 0.03 mol/L sodium periodate in DI Nanopure water. The

mixture was protected from light and stirred overnight at room temperature for reaction,

followed by 48 h of dialysis. The purified oxidized Lact-AM 53 (i.e., Lact-AM 53-Ox)
homopolymer was freeze-dried for SWCNT dispersion.

3.2.1.2 Complexation of Carbon Nanotubes by Glycopolymers
Pristine CoMoCat SWCNT powder (SG65i grade, lot no. SG65i-L39), that is

enriched in small diameter (6,5) chirality species, was purchased from CHASM Advanced
Materials. SWCNT powder was dispersed in a total volume of 1 mL aqueous solutions of
synthetic glycopolymers by tip sonication (model VCX 130, Sonics and Materials, Inc.) in
an ice bath for 40 min at a power level of 8 W using a 2 mm diameter probe. The SWCNT-

glycopolymer mass ratio was 1:4 for all dispersions, with the SWCNT concentration being

either 0.1 or 0.25 mg/mL. Specifically, 0.25 mg/mL SWCNTs were dispersed in AM/LactAM copolymers that are denoted as 4:1, 17:1, 20:1, and 25:1 because of the availability of

enough quantities of synthetic polymers. The rest of the dispersions was prepared using 0.1

mg/mL SWCNTs. Supernatant dispersions were collected after 90 min of centrifugation at
17,000g and 19 °C in 100 uL aliquots and used as stock samples. The differences in starting

SWCNT quantities in four Lact-copolymers mentioned above were accounted for by

dividing absorbance values across the entire spectral wavelengths by 2.5 when comparing
the dispersion outcome of various Glyco-SWCNT complexes. The capability of each
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glycopolymer in dispersing SWCNTs was examined by producing three repeats of each

sample. In addition, 0.36 mg/mL free sugar P-lactose, 0.04 mg/mL PAM backbone (MW
44.7 kDa), and their mixtures of 0.36 mg/mL free sugar-0.04 mg/mL PAM were tested for
stabilizing 0.1 mg/mL SWCNTs in water.

Optical spectroscopy characterization including vis-NIR absorbance and NIR
fluorescence measurements were performed on a NS3 NanoSpectralyzer (Applied
NanoFluorescence, LLC) using a 10 mm path length quartz cuvette. A fixed excitation
wavelength of 532 nm laser was used for acquiring NIR fluorescence spectra. The

concentration of SWCNTs in aqueous glycopolymer solutions was calculated using an

extinction coefficient of 0.02554 L mg-1 cm-1 at 800 nm wavelength. All samples were
diluted 10 times in DI water for spectroscopy measurements unless indicated otherwise.

3.2.1.3 Interactions of Glycopolymer Coatings with Surfactants and DNA

Sodium deoxycholate (SDC) (98%, BioXtra) and sodium dodecyl sulfate (SDS)
used for glycopolymer/surfactant interactions were acquired from Sigma-Aldrich. Single

stranded DNA, (GT)20 sequence, used for glycopolymer/DNA interactions was purchased
from Integrated DNA Technologies. Stock solutions of 10 mass % SDS, SDC, and DNA

were prepared for glycopolymer coating modulation at room temperature. Initially, stock

SWCNT samples prepared in glycopolymers (i.e., AM/Lact-AM 4:1 copolymer and Lact

AM 415 homopolymer) were diluted with a factor of 10x in DI water. Then, a small aliquot
of 3 uL solutions of dispersing agents (i.e., SDS, SDC, and DNA) was added to 300 uL of
diluted glyco-SWCNT samples to obtain a final concentration of 0.1 mass % dispersing

molecules. The mixtures were bath sonicated for 1 hour at room temperature for optical
spectroscopy characterization. In addition, aqueous dispersions of 0.4 mg/mL (GT)20-0.1
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mg/mL SWCNTs were prepared by tip sonication in an ice bath for 40 min at a power level

of 8 W, and supernatant dispersions were collected after centrifugation at 17,000g for 90
min. The stock supernatant samples of (GT)20-SWCNTs were diluted with a factor of 10x

in DI water. Then, a small aliquot of 3 uL of aqueous solutions of 10 mass % glycopolymers
(i.e., AM/Lact-AM 4:1 copolymer and Lact-AM 415 homopolymer) was added to a 300

uf sample of diluted (GT)20-SWCNTs to obtain a final concentration of 0.1 mass %
polymers. The mixture was bath sonicated for 1 hour at room temperature for
DNA/glycopolymer coating interaction experiments.
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Table 3. List of Glycopolymers Used for Producing Aqueous Dispersions of SWCNTs.
R^O\jjA

Glycopolymers

Glc, R, = H, R2 = OH, R3 = H. R4 = OH

r,

GIcNAc, R, = H, R2 =NHAc, R3 = H, R4 = OH
Gal, R, = H, R2 = OH, R3 = OH, R4 = H
Man, R4 = OH, R2 = H, R3 = H, R4 = OH
Lact, R4 = H, R2 = OH, R3 = H, R4 = O-Gal

NH
\
V°
/-x r
I.
I, .
N3—( y-H—"T'-f- '- 'r -OCN
J \=z 1
x
y'n

polymer characterization

AM x

glycosylacrylamide y

chain length n

MW“ (kDa)

3
4

1

50

Man-copolymer

I

87

23.3
44.2

Gal-copolymer

4

1

50

26.8

GlcNAc-copolymer

6

1

63

44.2

glycopolymers

abbreviations

Glc-copolymer

Lact-copolymer (25:1)

AM/Lact-AM 25:1

53

112.6

AM/Lact-AM 20:1

25
20

1

Lact-copolymer (20:1)

1

25

44.6

Lact-copolymer (17:1)

AM/Lact-AM 17:1

17

I

29

45.7

Lact-copolymer (7:1)

AM/Lact-AM 7:1

7

1

5

4.9

Lact-copolymer (4:1)

AM/Lact-AM 4:1

4

1

2

1.5

Lact-copolymer (1:2)

AM/Lact-AM 1:2

1

2

5

4.5

Lact-homopolymer (0:9)

Lact-AM 9

0

1

9

Lact-homopolymer (0:53)

Lact-AM 53

0

]

53

3.7
21.1

Lact-homopolymer (0:85)

Lact-AM 85

0

1

85

33.7

Lact-homopolymcr (0:415)

Lact-AM 415

0

1

415

“Average molecular weight determined by the ’H NMR spectrum of the glyccipolymer.
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164.1

3.3

Results and Discussion

3.3.1 A Small Library of Precision Synthesized Glycopolymers
Early work on dispersions of carbohydrate-coated SWCNTs has demonstrated the
wrapping of nanotubes by natural polysaccharides with glucose units, such as
schizophyllan, curdlan, amylose, and starch.61,98,103,104 Dispersions of SWCNTs by these

polysaccharides often required the activation of helical structure formation by complexing

with iodine or modulating the solvent property, such as adding dimethyl sulfoxide in water.

These glucose-containing polysaccharides adsorbed on SWCNTs via van der Waals
interactions and formed ordered, helical structures through interactions of the hydrophobic

face of the pyranose rings (i.e., the 2-OH side of the glucose unit) and the hydrophobic

surface of nanotubes.96,105 Furthermore, the helical conformation of polysaccharides was

potentially stabilized by hydrogen bonds formed between adjacent residues.96 Based on
these previously known stabilization approaches of SWCNTs by polysaccharides, the

capability of synthetic glycopolymers was examined with monosaccharide and

disaccharide groups in dispersing nanotubes in water (Figure 3.3a).
Two types of glycopolymers were investigated in this work: 10 copolymers from
AM and glycosylacrylamide monomers (i.e., AM/Glyco-AM) and 4 homopolymers from

lactosylacrylamide (i.e., Lact-AM) monomer only. Table 3 lists the glycopolymers used
for producing aqueous dispersions of SWCNTs in this work. For copolymers, four of them
are monosaccharide-containing polymers synthesized from D-galactose (Gal), D-glucose

(Glc), N-acetyl-D-glucosamine (GlcNAc), and D-mannose (Man), respectively. Six

disaccharide-containing copolymers were synthesized from P-lactose (Lact), which
contains both Glc and Gal, to produce polymers with various sugar densities (i.e., y/x ratios
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of Lact-AM and AM units) and polymer chain lengths (i.e., repeating unit n). In addition,
Lact-homopolymers with four different chain lengths were synthesized to elucidate the role

of polymer length on stabilizing SWCNTs while maintaining a constant sugar density.
3.3.2 Dispersions
Glycopolymer-wrapped SWCNT complexes (Glyco-SWCNTs) were prepared by
probe tip sonication of SWCNTs in aqueous solutions of glycopolymers above.

Dispersions of each Glyco-SWCNT sample were performed in three repeats. For SWCNTs
prepared in aqueous solutions of monosaccharide-containing copolymers, nanotubes

formed pellets upon centrifugation, resulting in clear supernatant solutions (Figure 3.3b).
It is noteworthy to mention that Glc-copolymers produced a SWCNT dispersion of faint
grayish color; however, the dispersion outcome was not significant.
In addition, copolymers with other monosaccharides (Gal, GlcNAc, Man) did not

result in effective dispersions of SWCNTs in water. Interestingly, when a disaccharide
Lact-copolymer (i.e., AM/Lact-AM 17:1) was utilized, dark supernatant dispersions of

SWCNTs were consistently obtained in water (Figure 3.3b). It was found that the identity

of carbohydrate groups plays an important role in encapsulating SWCNTs because a
glycopolymer with Lact residues composed of Glc and Gal stabilized nanotubes, while
those with monosaccharides Glc and Gal, respectively, did not produce stable dispersions

of SWCNTs (Figure 3.4). It was speculated that the disaccharide Lact potentially makes

glycopolymers less flexible and imposes a special wrapping conformation on the nanotube
surface while promoting multivalent interactions between hydrophobic faces of sugar rings
and the hydrophobic surface of SWCNTs (Figure 3.3c).
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- Lact-copolymer
- Man-copolymer
- Gal-copolymer
- Glc-copolymer
- GIcNAc-copolymer
- PAM (polyacrylamide)
- Free Lact
- Free Lact + PAM

Figure 3.4. Absorbance spectra of SWCNTs in aqueous solution of glycopolymers, free
sugar P-Lact, polyacrylamide (PAM), and a mixture of free Lact and PAM. All stock
samples were diluted by a factor of 10x in DI water for vis-NIR absorbance measurements.
SWCNT sample obtained from Lact-copolymer (i.e., AM/Lact-AM 17:1) was prepared
using 0.25 mg/mL SWCNTs in the starting mixture. Remaining samples were prepared
using 0.1 mg/mL SWCNTs in the starting material.
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Wavelength (nm)
Figure 3.5. Optical characterization of Glyco-SWCNT samples. (a) Normalized
absorbance spectra and (b) corresponding fluorescence spectra of SWCNT samples
prepared in aqueous solutions of copolymers with monosaccharides (Gal, Glc, GlcNAc,
Man) and disaccharide (Lact). Before normalization, both absorbance and fluorescence
values across the entire spectral wavelengths for Lact-SWCNTs were divided by 2.5 to
account for the difference in nanotube concentration used in initial dispersions. Lactcopolymer used here is AM/Lact-AM 17:1.
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3.3.3 Absorbance and Fluorescence Spectra Analysis

The corresponding absorbance and fluorescence spectra of aqueous dispersions of
SWCNTs in Lact-copolymers (i.e., AM/Lact-AM 17:1) showed characteristic optical
transition peaks of nanotubes (Figures 3.4 and Figure 3.5). Particularly, E11 and E22
transition peak features of semiconducting tubes were clearly shown for Lact-SWCNT
complexes in Figure 4a. These sharp, discrete absorption peaks obtained for Lact-

SWCNTs, compared with little to no absorption peaks obtained for nanotubes in
monosaccharide-containing copolymers, are indicative of uniform dispersions of SWCNTs

stabilized by Lact-copolymers.
In addition, well-dispersed Lact-SWCNTs exhibited nanotube photoluminescence

in the NIR region, indicating individually dispersed nanotubes in water (Figure 3.5b).
Although optical transition peaks with low absorbance values were observed for one Glc-

SWCNT sample, other dispersion trials resulted in samples without clear peak features in

both absorption and fluorescence spectra, like those obtained from SWCNTs prepared in

other copolymers with monosaccharides (Figure 3.5). In addition, we examined

capabilities of free sugar P-lactose, PAM backbone, and a mixture of free P-lactose and
PAM in dispersing SWCNTs; however, none of them resulted in aqueous dispersions of

nanotubes (Figure 3.4). Consequently, we selected Lact-polymers to study the roles of

carbohydrate identity and specific polymer characteristics in stabilizing SWCNTs in
aqueous environments.
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Figure 3.6. Optical characterization of aqueous dispersions of SWCNTs by Lactglycopolymers with various Lact densities (i.e., y/x) and polymer chain lengths (i.e., n). (a)
Normalized absorbance spectra and (b) absorbance values at the maximum E11 peak
wavelength of SWCNT/Lact-copolymer samples as a function of Lact density in the
copolymer. (c) Normalized absorbance spectra and (d) absorbance values at the maximum
E11 peaks of SWCNT/Lact-homopolymer samples as a function of polymer chain length.
Absorbance values in (b,d) were obtained from the original spectra of stock samples that
were diluted by a factor of 10x in DI water. As a guide for the eye, logarithmic fits were
applied to the data. The error bars were obtained from minimum and maximum values of
three repeats.
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AM/Lact-AM
AM/Lact-AM
AM/Lact-AM
AM/Lact-AM
AM/Lact-AM
AM/Lact-AM

25:1
20:1
17:1
7:1
4:1
1:2

Figure 3.7. Absorbance (a) and the corresponding fluorescence (b) spectra of aqueous
dispersions of SWCNTs in Lact-copolymers with different Lact densities. All stock
samples were diluted by a factor of 10x in DI water for optical characterization. SWCNT
samples obtained from AM/Lact-AM copolymers of 4:1, 17:1, 20:1, and 25:1 were
prepared using 0.25 mg/mL SWCNTs in the starting mixture. Remaining samples were
prepared using 0.1 mg/mL SWCNTs in the starting material.

Figure 3.8. Absorbance (a) and the corresponding fluorescence (b) spectra of aqueous
dispersions of SWCNTs in Lact-homopolymers with different polymer chain lengths. All
stock samples were diluted by a factor of 10x in DI water for optical characterization. All
dispersions were prepared using 0.1 mg/mL SWCNTs in the starting mixture.
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Figure 3.9. Normalized absorbance spectra of SWCNTs dispersed in aqueous solutions
of Lact-AM 415 homopolymer measured over a period of 5 weeks.

3.3.4 Lactose-containing Polymers
A library of lactose-containing polymers was created to further investigate the
important roles of carbohydrate ligand density and polymer chain length in effectively

stabilizing SWCNTs in water (Figure 3.6). The resulting Glyco-SWCNT complexes
exhibited nanotube photoluminescence in the NIR. The absorbance and fluorescence
spectra of various complexes are shown in Figures 3.7 and 3.8. In general, we observed

enhanced dispersion quality and yield of SWCNTs as a function of increasing sugar density
when Lact-copolymers (AM/Lact-AM) with different sugar densities, y/x, were used to

stabilize SWCNTs (Figure 3.6a). These are indicated by the narrowing of spectral line

widths of absorption transition peaks and stronger intensities of Glyco-SWCNTs obtained

in Lact-copolymers with higher sugar densities. Subsequently, we plotted absorbance
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values of the maximum E11 peaks at wavelengths ranging from 998 to 1010 nm for various

Glyco-SWCNT dispersions as a function of sugar density (Figures 3.6b and 3.7).
We observed a monotonic increase in absorbance values at the maximum E11 peak
with increasing sugar density for SWCNT samples dispersed by Lact-copolymers,

indicating an increase in the dispersion yield of nanotubes. Particularly, two Lactcopolymers, 25:1 and 20:1, with the lowest sugar density y/x values of 0.04 and 0.05,

respectively, did not disperse SWCNTs despite their long polymer chain lengths of n being
53 and 25, respectively. On the other hand, the two highest dispersion yields of SWCNTs
were obtained for Lact-copolymers, 7:1 and 1:2, regardless of their short polymer chain

length (i.e., n = 5), because of their high sugar densities (i.e., y/x = 0.14 and 2, respectively).
Specifically, AM/Lact-AM 1:2 polymers stabilized roughly 32.7 ± 14.0 mg/L SWCNTs in
water, which corresponds to a dispersion yield of -33% of the starting SWCNT material.
However, an exception from this general trend was observed for SWCNT samples
using the AM/Lact-AM 4:1 polymer; the short chain length (n = 2) of which likely hindered

the effective dispersion of nanotubes via the formation of helical wrapping despite its
relatively high sugar density (i.e., y/x = 0.25). These findings suggest that a glycopolymer

with a polymer chain length of as small as n = 5 can effectively stabilize SWCNTs via
wrapping around a nanotube, given that the specific polymer contains enough sugar
density. These results provide important insights into the synergistic effects of

carbohydrate ligand identity (i.e., sugar unit and density) and polymer chain length of
glycopolymers in creating stable Glyco-SWCNT complexes in aqueous environments.
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3.3.5 Homopolymers
Based on this observation, the next investigation focused on the effect of
homopolymer chain length on stabilizing SWCNTs in water using Lact-homopolymers

while maintaining the sugar density (Figures 3.6c,d and 3.8). As shown in Figure 3.5c,

changes of normalized absorbance spectra were observed for aqueous dispersions of
SWCNTs by Lact-homopolymers with different chain lengths of n ranging from 9 to 415.

Specifically, SWCNTs stabilized by homopolymers Lact-AM 85 and 415 (longer chain
lengths n = 85 and 415) exhibited narrower spectral line widths and stronger peak

intensities at the maximum E11 peak, indicating well-dispersed Glyco-SWCNT complexes.
We further observed a sharp increase of absorbance values at the maximum E11

peaks for Glyco-SWCNTs as a function of increasing polymer chain length up to n = 85,
followed by a minor increase in the absorbance value with n = 415 (Figure 3.6d). This
indicates that the formation of an ordered folding structure of Lact-homopolymers on the

nanotube surface is enhanced with increasing polymer chain length up to roughly n = 85,
after which the dispersion efficiency of SWCNTs remains relatively stable. The
concentration of nanotubes in aqueous dispersions of SWCNTs stabilized by Lact-AM 415

was determined to be 37.6 ± 7.0 mg/L, corresponding to a nanotube dispersion yield of
-38%. We also observed no obvious changes in absorption peak features of SWCNT

samples over a period of 5 weeks, indicating the long-term stability of nanotubes stabilized
by Lact-AM 415 in water (Figure 3.9).
3.3.6 Oxidation of Pyranose Rings

It was reported that the hydrophobic interaction between the carbohydrate pyranose
rings and the surface of nanotubes contributes in stabilizing
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SWCNTs by

polysaccharides.97 Therefore, a preliminary study to break the pyranose ring in Lact-AM

53 homopolymers by periodate was investigated.

Briefly, carbohydrate residues in solutions of glycopolymers were chemically
oxidized by sodium periodate (30 mM) in DI H2O at room temperature overnight. After
the reaction, excess periodate was removed by dialysis against DI H2O, and the reaction
solution was lyophilized to obtain oxidized Lact-AM 53 (i.e., 53-Ox). Absorbance values

at the maximum E11 peaks of SWCNTs dispersed by Lact-AM 53-Ox decreased slightly
compared to those of nanotube samples in Lact-AM 53 (Figure 3.3d). This no significant
change could be due to the incomplete oxidation of sugar rings of Lact-AM 53-Ox that has
relatively long polymer chain length (i.e., n = 53), resulting in the slightly lower level of

stabilization of SWCNTs via the remaining portion of carbohydrate ring structures.
However, this finding does indicate that the hydrophobic interaction between the

carbohydrate rings and the surface of nanotubes is one of many interactions involved in
stabilizing SWCNTs by glycopolymers. Future work on utilizing oxidized glycopolymers

of short chain length with a controlled degree of oxidation should be conducted to provide
further insights into the effect of hydrophobic interactions exerted by sugar rings on

stabilizing SWCNTs in aqueous environments. Together, our findings demonstrated the
roles of carbohydrate identity and polymer chain length of glycopolymers on stabilizing
SWCNTs in water through facilitating the helical wrapping conformation of polymers.

70

Figure 3.10. Optical characterization and different coating interactions of Glyco-SWCNT
complexes prepared from copolymer (AM/Lact-AM 4:1) (a,c,e) and homopolymer (Lact
AM 415) (b,d,f) with surfactants and DNA. Normalized absorbance spectra of SWCNTs
complexed with (a) AM/Lact-AM 4:1 and (b) Lact-AM 415 before and after adding a final
concentration of 0.1 mass % SDC, SDS, and (GT)20 DNA, respectively, and (c,d) the
corresponding spectra in the 900-1100 nm wavelength range. Normalized fluorescence
spectra of SWCNTs complexed with (e) AM/Lact-AM 4:1 and (f) Lact-AM 415 before
and after adding a final concentration of 0.1 mass % SDC, SDS, and (GT)20 DNA,
respectively.
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Table 4. Glycopolymer-dispersed SWCNTs and the corresponding fluorescence
spectral changes of the maximum E11 emission peaks after adding SDC, SDS, and DNA.
Initial
Samples

Ao

Io

(nm)

(pW/nm)

Added
Molecules

lfinai

(nm)

1001.2 ±
0.8

SDC
AM/LactAM 4:1

1014.3
± 0.8

0.41 ±
0.05

1014.3 ±
0.8
1014.8 ±
2.7
985.3 ±
0.0

SDS
(GT)20
DNA

SDC
Lact-AM
415

1006.1
±2.8

0.94 ±
0.09

AA
(nm)

13.2 ± 1.3

0.0 ± 0.0
-0.5 ±2.7

20.8 ±2.8

I final

Ifinal/J 0

(pW/nm)
0.96 ±
0.11
0.49 +
0.07
0.24 ±
0.03
15.51 ±
0.24

2.35 ±
0.30
1.19 +
0.08
0.60 ±
0.10
16.73 ±
1.45

SDS

1002.8 ±
0.8

3.3 ± 2.7

1.42 ±
0.20

1.54 ±
0.27

(GT)20
DNA

1008.8 ±
0.9

-2.7 ±3.7

0.97 ±
0.13

1.04 ±
0.06

*The emission intensity ratio of nanotubes at the maximum Eu peak wavelengths of SWCNTs
was denoted as ^fmai/i0, where l0 and lfinai are the magnitude of EN emission peaks corresponding
to initial Glyco-SWCNTs and samples after adding various dispersing molecules (i.e., SDC, SDS,
and DNA). The spectral wavelength shift of the maximum E11 peak after adding various dispersing
molecules was calculated as AA = Ao — Afinai. Stock dispersions of Glyco-SWCNTs were diluted
by a factor of 10x in DI water before adding small aliquots of surfactants and DNA for NIR
fluorescence measurements. A fixed excitation wavelengths of 532 nm laser was used for
fluorescence spectra measurements. The standard deviation was obtained from three replicates.

3.3.7 SDC, SDS, DNA(GT)20 Competition

Next, the strength of the interaction between SWCNTs and glycopolymers was

investigated by measuring optical spectral changes of Glyco-SWCNTs upon addition of

SDC, SDS, and single-stranded DNA of (GT)20 (Figure 3.10). These molecules are often
used to produce well-dispersed nanotubes in water through noncovalent complexation.

Among them molecules, SDC is a surfactant known to bind strongly to the surface of
SWCNTs and SDS is a weaker surfactant in coating nanotubes compared to SDC in an
aqueous environment.55,59 (GT)20 DNA is a well-known recognition sequence that can

effectively disperse and purify a specific SWCNT chirality species because of its ability to
fold onto a nanotube to form a stable DNA-wrapped SWCNT hybrid.90,91
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Both SDC and SDS have been utilized previously to study the binding affinity of

DNA sequences to SWCNTs through displacing DNA coatings by surfactants using

absorption and fluorescence spectroscopy.87,106-109 Particularly, measuring fluorescence
spectral changes in the NIR has been proven to be an efficient way to probe the

complexation affinity of a dispersing molecule and a nanotube. Various coating materials
and solvents provide different local dielectric properties surrounding SWCNTs. The

nanotube photoluminescence is highly sensitive in detecting small changes in the
environmental dielectric constant in the form of spectral changes, such as solvatochromic
shifts (i.e., spectral shift) and changes in spectral width and intensity.110,111
3.3.7.1 Surfactant’s Effect on Glyco-SWCNT Complexes

First, we investigated the surfactant effect with two Glyco-SWCNT complexes that
were prepared from AM/Lact-AM 4:1 copolymers and Lact-AM 415 homopolymers,

representing poorly and well-dispersed nanotubes, respectively. Particularly, SWCNTs

dispersed in Lact-AM 415 homopolymers showed sharp absorption peaks, indicating
individually dispersed tubes. On the other hand, absorption peaks of SWCNT samples
obtained in AM/Lact-AM 4:1 showed broader spectral line widths, indicating small

bundles and possible aggregations of nanotubes (Figure 3.10a,b).
Absorbance values at the maximum E11 peaks remained relatively stable when
surfactants were added to Glyco-SWCNT samples. However, we found that SDC can

effectively displace glycopolymer coatings from nanotubes in both Glyco-SWCNT

complexes, as indicated by the spectral blue shifts (i.e., decrease in wavelength) of the

maximum E11 absorption peaks of nearly 8 and 15 nm, respectively, for SWCNTs dispersed
in Lact-copolymers and homopolymers (Figure 3.10c,d). Furthermore, the displacement of
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glycopolymer coatings from the surface of SWCNTs by SDC was clearly demonstrated by

fluorescence spectroscopy, which showed a spectral blue shift of nearly 21 nm and a 16.7fold increase in emission intensity for SWCNTs dispersed in Lact-homopolymers as

compared to a blue shift of roughly 13 nm and a 2.4-fold intensity increase for nanotube
dispersions in Lact-copolymers (Figure 3.10 e,f and Table 4). Particularly, the maximum

E11 peak wavelength after displacing Lact-AM 415 coatings by SDC shifted to 985 nm

corresponding to the E11 peak of SDC-coated (6,5) species, which is the most abundant

nanotube species (i.e., -40% of nanotube species) in the starting SWCNT material (Table
2).90,109 The emission peaks obtained for SDC-coated SWCNTs after displacing Lact-AM
415 homopolymers are much sharper than those of nanotube samples obtained by replacing

AM/Lact-AM 4:1 copolymer coatings.

These observations suggest that starting from individually dispersed SWCNTs
facilitates an efficient glycopolymer/surfactant exchange reaction and leads to an improved

surface coverage of nanotubes by surfactant coatings. This is demonstrated by the

significant increase in fluorescence intensity of SWCNTs after displacing Lact-AM 415
homopolymers, where nanotubes were protected from fluorescence-quenching species in

surrounding environments by SDC coatings. In comparison, no obvious changes were
observed for the absorption and fluorescence spectra of Glyco-SWCNT complexes after
adding a weak surfactant SDS, indicating that SDS was less likely to displace

glycopolymer coatings on SWCNTs (Figure 3.10 and Table 4).
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Figure 3.11. Absorbance and fluorescence spectra for (GT)20-SWCNT samples before
(i.e.,red line) and after (i.e., blue line) adding AM/Lact-AM 4:1 copolymer (a,c) and Lact
AM 415 homopolymer (b,d), respectively, at a final concentration of 0.1 mass %
glycopolymers. The increase in absorbance values in the wavelength range from 400 to
800 nm for DNA-SWCNT samples after adding glycopolymers is likely caused by the
absorption of excess, unbound Lact-polymers in solutions. The black lines are absorbance
and fluorescence spectra of aqueous solutions of 0.1 mass% AM/Lact-AM 4:1 and Lact
AM 415 only, respectively, without adding nanotubes.

Figure 3.12. Normalized absorbance (a) and the corresponding fluorescence (b) spectra of
aqueous dispersions of SWCNTs in Lact-AM 415 homopolymer and (GT)20 DNA. Both
samples were prepared using 0.1 mg/mL SWCNTs in the starting mixture and diluted by
a factor of 1Qx in DI water for optical characterization.
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3.3.7.2 (GT)20’s Effect on Glyco-SWCNT Complexes
Continuing, we investigated with (GT)20 DNA and observed a decrease of roughly
1.7-fold in fluorescence emission intensity at the maximum E11 peak for SWCNT samples

prepared in AM/Lact-AM 4:1 copolymers when (GT)20 DNA was added to Glyco-SWCNT
complexes (Figure 3.10 and Table 4). The spectral changes in nanotube photoluminescence

are caused by changes in dielectric environments of water surrounding nanotubes. The

decrease in emission intensity is likely due to possible interactions between loosely bound

AM/Lact-AM 4:1 copolymer coatings and DNA, leading to the reduced surface coverage

of SWCNTs and nanotube aggregations. However, we speculate that displacement of Lactcopolymers on the nanotube surface by DNA is not likely the case in this work. Oppositely,

we prepared aqueous dispersions of (GT)20-SWCNT hybrids and added AM/Lact-AM 4:1
copolymers and Lact-AM 415 homopolymers (Figure 3.11). As a result, no obvious

changes were observed for the absorbance spectra of (GT)20-SWCNT samples upon
adding glycopolymers. Surprisingly, SWCNT fluorescence measurements revealed a
nearly 6.7-fold increase in emission intensity when Lact-AM 415 homopolymer was added

to (GT)20-SWCNTs, indicating that Lact-AM 415 binds to nanotube stronger than (GT)20

DNA and further replace DNA coatings from the surface of SWCNTs (Figure 3.11d). This

is also supported by the optical spectra of SWCNT samples obtained from direct dispersion

in these two biopolymers. Specifically, nanotubes dispersed in Lact-AM 415 showed better
dispersion quality, exhibiting a sharper peak feature and higher emission intensity than that

of (GT)20-dispersed tubes (Figure 3.12).
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3.3.7.3 Significance
Combined, the results suggest that the binding affinities of certain glycopolymers
to SWCNTs could be similar to that of weak surfactant SDS, as no obvious spectral changes
were observed after adding SDS in Glyco-SWCNT samples. Moreover, glycopolymers

with proper structures could interact stronger with SWCNTs in water compared to wellknown dispersants of nanotubes, including DNA.

Future work will focus on the rational design of glycopolymers with unique
carbohydrate functionality and polymer structures, including the synthesis of
glycopolymers with trisaccharide groups, for complexation with SWCNTs. The creation
of stable, water-soluble Glyco-SWCNT complexes with distinct optical and carbohydrate
functionalities will open many possibilities in biological and biomedical applications such
as biochemical sensing and imaging advancement.

3.4

Conclusion

The complexation of glycopolymers and SWCNTs have been demonstrated in

water utilizing synthetic glycopolymers containing monosaccharide and disaccharide
groups. Particularly, we investigated a range of monosaccharide- and disaccharide lactose-

containing glycopolymers and revealed the synergistic effects of carbohydrate identity and
polymer chain length on stabilizing SWCNTs in water. Glycopolymers with
monosaccharides did not produce effective dispersions of SWCNTs. When disaccharide
lactose was introduced, well-dispersed SWCNTs were obtained, and the dispersion
outcome was strongly dependent on both the sugar density and the polymer chain length.
Moreover, Lact-copolymers with chain length as short as n being 5 enable the production

of stable, water-soluble Glyco-SWCNT complexes, given that the glycopolymer possesses
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a sufficient amount of sugar density. The highest dispersion yield of SWCNTs was
obtained in aqueous solutions of Lact-AM 415 homopolymers, which were found to be
able to displace (GT)20 DNA, a well-known dispersant of SWCNTs, from the surface of
nanotubes. Taken together, this work demonstrated the important roles of both

carbohydrate ligand identity and polymer chain length of glycopolymers in stabilizing
SWCNTs through the formation of helical wrapping structures on the nanotube. The
resulting stable, water-soluble Glyco-SWCNT complexes possess the intrinsic

fluorescence properties of nanotubes. These findings offer important insights into
designing biomimetic glycopolymers of specific structures and creating fluorescent,
carbon-based nanocomplexes of distinct optical properties and carbohydrate functionalities
for developing potential applications in biology.
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CHAPTER IV
SYNTHESIS AND EVALUATION OF N-GLYCAN POLYMERS FOR THE

IMMUNOMODULATION EFFECTS OF MOUSE MACROPHAGE USING
NEWLY DEVELOPED HIGH-THROUGHPUT MULTIPLEX ASSAYS

4.1 Introduction
4.1.1

Synthesis and Evaluation of Novel a2,3- and a2,6-Sialyllactosyl Glycopolymers

Sialic acids are a very important class of carbohydrates that have been proven time and

time again to play a vital role in immunobiology, as well as in various stages throughout
different disease development, including their participation in hemagglutinin activity and
their anti-inflammatory capabilities.112-114 Over the recent decade, numerous of different
sialic acid-containing synthetic biomaterials have been developed to study sialic acid’s

bioactivities, immunomechanics, and therapeutic potentials39-45,47,48,51 via communication
with inhibitory Siglec receptors. Siglec-9, in particular, has a preferential affinity for a2,3-

linked sialyllactose and is widely believed to be a druggable target responsible for anti

inflammatory effects.24,26,28,29,115,116 Using CMFRP, we have successfully synthesized both
the novel a2,3- and a2,6-sialyllactosyl N-glycan polymers to be subjected to immunoassays

for the examination of their immunomodulation effects.
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To construct the novel a2,3- and a2,6-sialyllactosyl N-glycan polymers, sialyllactose

starting material was first aminated to yield sialyllactosamine, then acrylated to yield the

sialyllactosyl-acrylamide monomers.9,69,99 The monomers were subjected to CMFRP in
one-pot fashion to yield the resulting N-linked sialyllactosyl glycopolymers with an

acrylamide backbone, as well as both an aryl chain-end and an O-cyanate chain-end
functional units.9,69,99 The novel sialyllactosyl polymers were characterized by Proton
NMR (Figure 4.1 & Figure 4.2). With a straightforward synthetic approach, the

carbohydrate units are expressed via a N-linkage in a way that closely mimics the naturally
occurring glycoprotein counterparts. The novel a2,3- and a2,6-sialyllactosyl N-glycan

polymers are suitable biomimetics to be employed in immunoassays, which can elucidate
sialic acid’s immunomodulation effects on immune cell targets and facilitate further

understandings that will benefit future developments of therapeutic interventions.

R

One-Pot

Scheme 2. Straightforward synthesis of Sialyllactosyl N-glycan polymers from free
glycans via glycosylamine.
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Figure 4.1. 1H NMR spectrum of a2,3-sialylloctose glycopolymer (D2O, 400 MHz NMR).
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Figure 4.2. 1H NMR spectrum of a2,6-sialylloctose glycopolymer (D2O, 400 MHz NMR).
4.1.2

Conventional Immunoassays

The immune system protects the host through the ability to mobilize responses to
invading pathogens, toxins, or allergens as immune cells can distinguish self from non-self
via both innate and adaptive mechanisms117. Analytical measurements are required to

characterize the state and capability of immune cells, reveal the fundamental biology of
immunity, and establish distinct signatures for specific immune responses. In addition, they

provide insight into the evolution of disease, and aid the design of clinical diagnostics and
interventions62.
To evaluate immune cell modulation activities, cell surface markers and cytokine

release profiling are some of the most important categories to be examined.
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Conventionally, cell surface markers are identified by flow cytometry and confocal
imaging while cytokines are quantified by ELISA or immunobeads flow cytometry after

the treatment of cells118,119. In those cases, a lengthy time necessary for sample preparation

could be an issue for both ELISA and bead-based assays. Centrifuging and pipetting are
often applied for extraction of culture media and preparation of antibodies, followed by

measuring soluble mediators/indicators of interest. Multiple repetition of media

transferring via centrifuging and pipetting are inconvenient, low-throughput, and often

cause the loss of valuable reagent and analytes in the process. In addition, it is difficult to
handle large number of samples and their combinations. Furthermore, an in vitro model
system involving immune cell drug treatment should be capable of mimicking in vivo

cellular conditions. Assays carried out in two-dimensional (2D) cell cultures are limited in
terms of cell-cell and cell-matrix interactions that are crucial for cell-signaling and
activation, as well as for promoting proliferation and differentiation120.
To address these limitations, pillar/well chip platforms such as micropillar/microwell

chips and a 384-pillar plate that can facilitate miniaturized cell cultures and highthroughput biochemical and cell-based assays can be developed and put into use120. This

platform will have the potential of replacing the conventional multiwell plate assays, while
generating reliable data in a high-throughput low latency manner.
4.1.3

Miniaturized Immunoassays of Macrophage
In this study, pillar plate platforms were developed and employed121,122 where

bioprinted cells in biomimetic hydrogels on the pillar plates were coupled with a microwell
chip and a 384-well plate containing growth media, recombinant viruses, test compounds,

and reagents for cell culture, test, staining, and imaging in situ. Since this approach can
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simplify the process of 3D cell culture and multiplex cell-based assays, mouse macrophage
RAW 264.7 cells have been printed on the pillar plates as an immune cell model and tested
with lipopolysaccharide (LPS) and novel synthetic N-glycan polymers for immune cell

modulation. The goal was to investigate immune cell responses to modulating compounds
on the pillar plates and establish reliable multiplex and miniature immune cell assays in
high throughput, alternative to conventional microtiter well plate platforms.

Macrophages play significant roles in immune responses and are potential
contenders for immunomodulation that may effectively modify immunological processes

in cancers and infectious diseases123-125. In addition, the synthesized N-glycan polymers
can mimic the natural N-glycan conjugates and could potentially bind to lectin receptors
on RAW 264.7 cells for immune modulation applications10,12. Therefore, this model system

would be well suited for establishing multiplexed, immune cell printing and analysis on
the pillar plates and could be potentially used for elucidating the underlying mechanisms

of immune responses of macrophages.
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Figure 4.3. Pillar plate platforms for multiplex immune cell assays: Schematics for
profiling of immune cell responses using the pillar plate platforms. RAW 264.7 cells in
alginate are printed on the pillar plates using a microarray spotter and cultured by
sandwiching the well plates with growth media and test compounds. High-content cell
imaging can be performed on the pillar plates to assess changes in cell viability and
measure the expression level of both cell surface and intracellular markers after compound
exposure. Cytokines secreted from the activated cells into the well plates can be profiled
by microbead antibody array/flow cytometry.

4.2 Experiments
4.2.1

Materials and Methods

All solvents and reagents were purchased from commercial sources and were used as

received, unless otherwise noted. Deionized water was used as a solvent in all procedures.
Polymaleic anhydride-alt-1-octadecene (PMA-OD), alginate (alginic acid sodium salt),
0.01% poly-L-lysine (PLL), barium chloride (BaCl2), and LPS (from Escherichia coli
026:B6) were obtained from Sigma Aldrich (St. Louis, MO, USA). All primary antibodies

including BD Pharmingen™ FITC rat anti-mouse CD40, BD Pharmingen™ FITC rat anti
mouse CD1d, BD Pharmingen™ FITC hamster anti-mouse CD80, and BD Pharmingen™
FITC mouse anti-mouse I-A[d] were obtained from BD Biosciences (San Diego, CA,
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USA). Polyacrylamide, N-glucosyl polymer, N-galactosyl polymer, N-mannosyl polymer,

N-GlcNAc polymer, N-lactosyl polymer, N-a2,6-sialolactosyl polymer, and N-a2,3sialolactosyl polymer were synthesized in a previously reported method9,99. The
micropillar chip, the microwell chip, and the 384-pillar plate were purchased from Medical
& Bio Device (MBD) Korea (Suwon, Republic of Korea).

4.2.2

Cell Preparation on Pillar Plates
RAW 264.7 cells from ATCC were cultured in T-75 flasks with DMEM containing

25 mM glucose, 4.0 mM L-glutamine, 1 mM sodium pyruvate, 1% penicillin-streptomycin,
and 10% fetal bovine serum. For robust attachment of cell spots on the surface of pillar

plates, the micropillar chip and the 384-pillar plate were coated with 0.01% PMA-OD in
ethanol, an amine-reactive polymer, followed by printing 60 nL of a mixture of 0.0033%

PLL and 16.6 mM BaCh on the micropillar chip or printing 1 uL of the PLL-BaCh mixture
on the 384-pillar plate using a microarray spotter (S+ MicroArrayer from MBD Korea).

After trypsinization and centrifugation, the suspension of RAW 264.7 cells was mixed with
0.75% alginate and 0.5 mg/mL Matrigel, and then 60 nL of the mixture at a density of 3 x
106 cells/mL (180 cells/pillar) were printed on the micropillar chip with dried PLL-BaCl2

spots. Similarly, 1 |1L of the cell mixture at a density of 3 x 106 cells/mL were printed on
the 384-pillar plate with dried PLL-BaCl2 spots to obtain 3,000 cells/pillar. After 2-4

minutes of alginate gelation, the pillar plates with RAW 264.7 cells were sandwiched with
the microwell chip containing 950 nL of DMEM or the 384-well plate containing 50 uL of
DMEM, and then incubated in a 5% CO2 incubator at 37°C for 24 hours.
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4.2.3

Measurement of Cytotoxicity on Micropillar Chips after Treatment with LPS
LPS was dissolved and sonicated in DMEM at 0, 0.4, 2, 10, 50, and 250 |ig/mL.

These compounds, dissolved in DMEM, were dispensed into the microwell chip at 950 nL
per well (6 doses per compound, 14 replicates per dose). For compound exposure, the

micropillar chip with the RAW 264.7 cells was separated and sandwiched onto the

microwell chip with test compounds, and then incubated in a 5% CO2 incubator at 37°C

for 24 hours. For live/dead assays, the micropillar chip with the cells was rinsed twice with

a saline solution containing 140 mM NaCl and 20 mM CaCl2 for 10 minutes each, and
then stained with 1 uM calcein AM and 1 uM ethidium homodimer 1 in the saline solution

for 1 hour. This was followed by rinsing twice with the saline solution for 10 minutes each
and complete drying for at least 3 hours in the dark. For rapid fluorescent cell image

acquisition at 15 frames per second (FPS), the micropillar chip was scanned with an
automated epifluorescence microscope (S+ scanner from MBD Korea). Green and red
fluorescent cell images were obtained at 4X magnification with the Olympus UPLFLN 4X
(numerical aperture (NA) 0.13, f-number 26.5, and depth of field (DOF) ~ 32.3 |im)

(Olympus, Tokyo, Japan), and a green filter (XF404 from Omega Optical) and a red filter

(TxRed-4040C from Semrock). The images were batch-processed using ImageJ (NIH) to
extract the fluorescent intensity from each cell spot on the micropillar chip. The fluorescent
intensities were plotted using S+ Chip Analysis (MBD Korea). The sigmoidal dose
response curves (variable slope) and IC50 values (i.e., concentration of the compound

where 50% of cell viability/growth inhibited) were obtained using the following equation:
Top — Bottom
Y = Bottom + .1 + iQ(LogIC50-X-)xH_
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Where IC50 is the midpoint of the curve, H is the hill slope, X is the logarithm of
test concentration, and Y is the response (% live cells), starting from the top plateau (Top)

of the sigmoidal curve to the bottom plateau (Bottom).
4.2.4

Measurement of Cytotoxicity 96-well Plates after Treatment with LPS

For comparison with cytotoxicity data obtained from the pillar chip, cytotoxicity
assays were performed with the positive compound, LPS in a 96-well plate. Briefly, RAW
264.7 cell suspension was prepared in DMEM at a cell density of 50,000 cells/mL, 100 uf

of this cell suspension was seeded in a 96-well plate at 5000 cells/well, and then the 96-

well plate with RAW 264.7 cells was incubated in a 5% CO2 incubator at 37°C for 24
hours. For compound exposure, the old DMEM medium was removed from the 96-wells,

100 |1L of fresh DMEM containing LPS at concentrations of 0, 0.4, 2, 10, 50, 250 |ig/mL

was added into the 96-wells, and the 96-well plate was incubated in a 5% CO2 incubator at
37°C for 24 hours. Each LPS test condition consisted of 4 replicates. For live/dead assays,

the LPS solution was removed from the 96-wells, and each 96-well with cells was rinsed

twice with 100 uf of the saline solution for 10 minutes each and then stained with 100 uf

of 1 |iM calcein AM and 1 |iM ethidium homodimer-1 in the saline solution for 1 hour.
Fluorescent cell images were acquired with the S+ scanner using the green and red filters.

4.2.5

Measurement of Cell Surface Markers on Micropillar Chips after Treatment

with LPS and N-glycan Polymers

The micropillar chip, with RAW 264.7 cells, was sandwiched with the microwell
chip containing 10 ug/mf of LPS (positive control) and 1250 ug/mf of the N-glycan

polymers and incubated in a 5% CO2 incubator at 37 ◦C for 24 h. As a negative control,
the growth medium alone was used. Each test condition consisted of 4 replicates. The
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micropillar chip was separated and rinsed twice with Tris-buffered saline (TBS) for 10 min
each. The cells were fixed in a mixture of ice-cold methanol and acetone at 1:1 ratio for 10

min at room temperature. The micropillar chip with fixed cells was rinsed twice with TBS

for 3 min each, and then incubated with SuperBlock blocking buffer for 1 h at room
temperature. The primary antibodies including FITC-labeled rat anti-mouse CD40, CD1d,

CD80, and I-A[d] were diluted in the blocking buffer at 1:50 ratio to obtain the final
concentration of 0.01 mg/mL. The cells were stained with 0.01 mg/mL of the primary
antibodies at 4 ◦C overnight, followed by staining with 1 ug/mL DAPI for 30 min and

rinsing twice with TBS for 10 min each. After drying the micropillar chip for at least 3 h

in the dark, fluorescent images were acquired from the cells using the S+ scanner and the
fluorescent intensity was extracted with ImageJ to measure changes in the expression level

of cell surface biomarkers.
4.2.6

Measurement of Cell Surface Markers in 96-well Plates after Treatment with
LPS

The RAW 264.7 cells in a 96-well plate were exposed to 10 ug/mL of LPS for 24
h at 37 ◦C, rinsed twice with phosphate-buffer saline (PBS) buffer at pH 7.4 for 5 min each,

and then fixed in 4% paraformaldehyde for 30 min at room temperature. The fixed cells
were rinsed twice with the PBS buffer solution for 5 min each and incubated with a

blocking buffer solution containing 10% BSA and 0.1% sodium azide in the PBS buffer

solution for 30 min at 4 ◦C. The primary antibodies, including FITC-labeled rat anti-mouse

CD40, CD1d, CD80, and I-A[d], were diluted in the blocking buffer at 1:50 ratio to obtain
the final concentration of 0.01 mg/mL. The cells were stained with 0.01 mg/mL of the
primary antibodies at 4 ◦C overnight, followed by staining with 1 ug/mL DAPI for 10 min
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and rinsing twice with PBS for 5 min each. For flow cytometry, a portion of the cells was

collected and resuspended in 1% BSA and 0.5% sodium azide in PBS and transferred to
Falcon roundbottom tubes. For each test condition, 50,000 events were recorded each time
with BD FACSCanto™ II Cell Analyzer, and data were assessed using BD FACSDiva
software (BD Bioscience, Mountain View, CA). For confocal imaging, the remaining
portion of the cells was collected and resuspended in ProLong™ Gold anti-fade reagent,

followed by spotting on microscope slides and image acquisition using Nikon A1RSI
confocal microscope. Fluorescent cell images were processed using the NIS Elements AR

software.
4.2.7

Measurement of Cytokine Release on 384-pillar Plates after Treatment with

LPS and N-glycan Polymers

The 384-pillar plate with RAW 264.7 cells was sandwiched with the 384-well plate

containing 50 uL of 10 ug/mL LPS (positive control) and 50 uL of 1250 ug/mL N-glycan
polymers and incubated in a 5% CO2 incubator at 37 ◦C for 24 h. All compounds dissolved
in DMEM were sonicated and filtered through a 0.2 um membrane. As a negative control,
the growth medium alone was used. Each test condition consisted of 4 replicates. The

supernatant collected from the 384-well plate was centrifuged at 200 g for 4 min and
shipped to Eve Technologies (Calgary, Alberta, Canada) for the mouse cytokine 31-plex
discovery assay.

4.2.8

Measurement of Cytokine Release from in 96-well Plates after Treatment with
LPS

RAW 264.7 cells cultured in a 96-well plate were exposed to 10 ug/mL of LPS

(positive control) and DMEM alone (negative control) in a 5% CO2 incubator at 37 ◦C for
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24 h. Each test condition consisted of 4 replicates. The cell supernatant collected from the

96-well plate was centrifuged at 200 g for 4 min and shipped to Eve Technologies for the

mouse cytokine 31-plex discovery assay.

4.2.9

Statistical Analysis
Statistical analysis was performed with GraphPad Prism 8.0 (La Jolla, CA, USA)

to compare the levels of biomarkers expressed and cytokines released from the micropillar

chip and the 384-pillar plate. One-way analysis of variance (ANOVA) was used to compare
the mean values of the compound obtained from RAW 264.7 cells. Statistically significant
differences between control and test conditions were indicated by * for P < 0.05, ** for P

< 0.01, and *** for P < 0.001 (n = 4).

Figure 4.4. Cytotoxicity of RAW 264.7 cells on the micropillar chip and in the 96-well
plate after treatment with lipopolysaccharides (LPS) for 24 hours. (A) Images of RAW
264.7 cells treated with LPS on the micropillar chip. The diameter of the entire cell spot
was 0.75 mm. (B) Images of RAW 264.7 cells treated with LPS in the 96-well plate. Green
and red dots represent live and dead RAW 264.7 cells after staining with 1 ^M calcein AM
and 1 |1M ethidium homodimer-1. (C) Dose response curves obtained from RAW 264.7
cells on the micropillar chip (n = 14) and in the 96-well plate (n = 4).
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Control

LPS

Figure 4.5. Expression levels of cell surface markers on RAW 264.7 cells after treatment
with the growth medium (negative control) and LPS (positive control) for 24 hours: (A)
the micropillar chip and (B) the 96-well plate. To determine statistically significant
differences between no LPS control and LPS exposure conditions, one-way ANOVA
analysis was performed, and the results were indicated as * for p < 0.05, ** for p < 0.01,
and *** for p < 0.001 (n = 4). No indication means p > 0.05.
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4.3 Results and Discussion
4.3.1

Cytotoxicity of RAW 264.7 cells Against LPS and N-glycan Polymers
Prior to testing immune cell responses to synthetic N-glycan polymers, we

established cytotoxicity assays with RAW 264.7 cells and LPS on the micropillar chip and

in the 96-well plate. RAW 264.7 cell, a mouse macrophage cell line, is often used in
immune studies along with LPS, which is an immune stimulator of the cell126,127. In this

study, RAW 264.7 cells were cultured on the two different platforms, and their responses
to LPS stimulation were compared to establish multiplex and miniature immune cell assays

on the pillar plates. Alginate used for cell encapsulation on the pillar plates has been known
to have no immunomodulation activity on RAW 264.7 cells128,129. In addition, Matrigel is
often used for 3D macrophage co-culture assays130,131. Therefore, a mixture of alginate and

Matrigel was selected to encapsulate RAW 264.7 cells on the micropillar chip and the 384pillar plate in this study (Figure 4.3). Briefly, RAW 264.7 cell monolayers in the 96-well

plate, as well as bioprinted RAW 264.7 cells in the alginate-Matrigel mixture on the

micropillar chip, were exposed to different concentrations of LPS for 24 h and stained with
calcein AM and ethidium homodimer-1 to obtain dose response curves (Figure 4.4). As a
result, LPS showed dose-dependent cytotoxicity against RAW 264.7 cells on the

micropillar chip (Figure 4.4A). Green and red dots represent live and dead cells,

respectively. This result indicates that RAW 264.7 cells were successfully encapsulated in
the mixture of alginate and Matrigel on the micropillar chip and could be cultured over

time without basal toxicity issues from the hydrogels and the crosslinker, BaCl2. We have
already demonstrated that several human cell types can be encapsulated in alginate,
Matrigel, fibrin, PuraMatrix, and alginate-Matrigel and cultured on the chip platform for
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toxicity assessment121,123,132-134. Similarly, LPS showed dose-dependent cytotoxicity

against RAW 264.7 cells in the 96-well plate (Figure 4.4B). Interestingly, the dose response
curve obtained from the 96-well plate was well correlated with that from the micropillar

chip (Figure 4.4C). These results indicate that the micropillar chip can be used for

evaluating the viability of RAW 264.7 cells after treatment of large molecules like LPS as
an alternative to the 96-well plate. Importantly, our approach can reduce the assay volume

as much as 100-fold while obtaining essentially identical data.

DAPI

FITC

DAPI

Merged

FITC

Merged

Figure 4.6. Representative confocal images of cell surface markers on RAW 264.7 cells
in a 96-well plate after treatment with the growth medium (control) and LPS for 24 hours:
(A) CD40, (B) CD80, (C) CD1d, and (D) Class II MHC.
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Figure 4.7. Expression levels of cell surface markers on RAW 264.7 cells after treatment
with N-glycan polymers for 24 hours. Fluorescent intensity of (A) CD40, (B) CD80, (C)
CD1d, and (D) Class II MHC makers were determined by staining RAW 264.7 cells with
FITC-labeled primary antibodies. The numbers indicate RAW 264.7 cells on the
micropillar chip treated with: (1) growth medium alone, (2) LPS, (3) polyacrylamide, (4)
N-glucosyl polymer, (5) N-galactosyl polymer, (6) N-mannosyl polymer, (7) N-GlcNAc
polymer, (8) N-lactosyl polymer, (9) N-a2,3-sialolactosyl polymer, and (10) N-a2,6sialolactosyl polymer. To determine statistically significant difference between growth
medium control and N-glycan polymer exposure conditions, one-way ANOVA analysis
was performed, and the results were indicated as * for p < 0.05, ** for p < 0.01, and ***
for p < 0.001 (n = 4). No indication means p > 0.05.

4.3.2

Changes in the Expression Levels of Cell Surface Markers after Treatment

with LPS and N-glycan Polymers
Prior to assessing potential immune responses of N-glycan polymers, we

established immunofluorescence assays on the micropillar chip and rapidly measured
changes in cell surface markers on RAW 264.7 cells after LPS treatment. LPS has been
known to induce expression of specific cell surface markers and secretion of cytokines
from RAW 264.7 cells126. Flow cytometric studies indicate that cell surface markers
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including CD40, CD80, and class II major histocompatibility complex (MHC) antigens
were upregulated on LPS-treated RAW 264.7 cells126. To establish a proof-of-concept

study, the immune response of RAW 264.7 cells to LPS on the micropillar chip was
examined by sandwiching the micropillar chip with RAW 264.7 cells onto the microwell
chip containing 10 ug/mL of LPS and staining the cells with FITC-labeled primary
antibodies including rat anti-mouse CD40, CD1d, CD80, and I-A[d]. As a result, LPS

induced high levels of CD40, CD80, CD1d, and class II MHC markers expression (Figure
4.5A), which were well consistent with the flow cytometric data from literature126. To
further validate the results from the micropillar chip, we conducted immunofluorescence

assays in a 96-well plate and examined the same cell surface CD1d, all other surface

markers data from both flow cytometry and confocal imaging (Figure 4.6) were aligned
well with the data from the micropillar chip, thus confirming that the micropillar chip

platform can be a practical tool for examining cell surface markers upon compound
treatment.
With successful establishment of immunofluorescence assays on the micropillar

chip, we measured potential immune responses of N-glycan polymers. In this study, we
focused on Siglecs which recognize sialyl glycoconjugates for immune response and are
potential targets for immunomodulation for the treatment of cancers as well as

inflammatory, autoimmune, allergic, and infectious diseases135. Synthetic sialyl
glycoconjugates may affect the expression of cell surface antigens on macrophages but
have not been fully investigated so far. We selected N-a2,3-sialolactosyl polymer and Na2,6-sialolactosyl polymer as Siglecs-targeting biomimetic glycoligands. In addition, Nglucosyl polymer, N-galactosyl polymer, N-mannosyl polymer, N-GlcNAc polymer, and
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N-lactosyl polymer were synthesized for comparison. The modulation effects of these N-

glycan polymers on RAW 264.7 cells were evaluated on the pillar plate platforms by
measuring the expression levels of cell surface biomarkers and the secretion levels of

cytokines, respectively. Briefly, the micropillar chip, with RAW 264.7 cells, was
sandwiched onto the microwell chip containing 1250 ug/mL of the N-glycan polymers and

stained with FITC-labeled primary antibodies including rat anti-mouse CD40, CD1d,

CD80, and I-A[d]. As a result, the N-sialolactosyl polymers (compounds 9 and 10) induced
significantly high expression levels of CD40, CD80, CD1d, and class II MHC markers
(Figure 4.7), as compared to DMEM (negative) and LPS (positive) controls. In particular,

N-a2,3-sialolactosyl polymer (9) showed the highest induction of all four cell surface
markers, indicating its strong macrophage modulation activity. This result is correlated

well with precedent reports that macrophage Siglecs prefer binding glycans with a
Neu5Aca2-3Gaipi sequence136. In addition, N-galactosyl polymer (5) induced higher

expression level of CD80 and class II MHC cell surface markers. This could be because it
may target macrophage galactose binding lectin (MGL) as well, which is a C-type lectin
on macrophages137. MGL is an oligomeric type II transmembrane protein and serves as an
important immune cell target as well138. These results indicate that the N-glycan polymers

have a strong immunomodulating effect on RAW 264.7 cells. The N-sialolactosyl polymer

may serve as a lead Siglec ligand with improved binding affinity and selectivity, which
would represent invaluable tool and candidate for exploring therapeutic opportunity of
sialic acid-mediated Siglec recognition.
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Figure 4.8. Secretion of cytokines after treatment of RAW 264.7 cells with LPS for 24
hours. Changes in cytokine release from RAW 264.7 cells on the 384-pillar plate and in
the 96-well plate were measured in the presence of the growth medium alone (LPS -) and
LPS (LPS +). To determine statistically significant difference between no LPS control and
LPS exposure conditions, one-way ANOVA analysis was performed, and the results were
indicated as * for p < 0.05, ** for p < 0.01, and *** for p < 0.001 (n = 4). No indication
means p > 0.05.
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Figure 4.9. Secretion of cytokines after treatment of RAW 264.7 cells with N-glycan
polymers for 24 hours. The concentrations of (A) IL-6, (B) IL-10, and (C) VEGF were
determined by the mouse cytokine panel assay. The numbers indicate RAW 264.7 cells on
the 384-pillar plate treated with: (1) growth medium alone, (2) LPS, (3) polyacrylamide,
(4) N-glucosyl polymer, (5) N-galactosyl polymer, (6) N-mannosyl polymer, (7) N-GlcNAc
polymer, (8) N-lactosyl polymer, (9) N-a2,3-sialolactosyl polymer, and (10) N-a2,6sialolactosyl polymer. One-way ANOVA analysis indicated as follows: * for p < 0.05, **
for p < 0.01, and *** for p < 0.001 (n = 4). No indication means p > 0.05.
4.3.3

Changes in Secretion of Cytokines after Treatment with LPS and N-glycan
Polymers

With the established immunofluorescence assays on the micropillar chip, we

profiled cytokines released from RAW 264.7 cells by printing RAW 264.7 cells in alginate
on the 384-pillar plate, a large-size micropillar chip, and sandwiching it onto a 384-well

plate containing 10 ^g/mL of LPS for 24 h. The 384-pillar plate was introduced due to a
relatively large volume of samples (50 ^L) required for the mouse cytokine 31-plex
discovery assay. For validation of the 384-pillar plate, RAW 264.7 cell monolayers were

cultured in a 96-well plate and exposed to 10 ^g/mL of LPS for 24 h. The solutions in the
384-well plate (complementary to the 384-pillar plate) and the 96-well plate were collected
to determine the secretion levels of cytokines by the mouse cytokine 31- plex discovery

assay. As a result, LPS induced the production of TNF-a, IL-6, and IL-10 significantly, but

a minimum amount of VEGF production from RAW 264.7 cells on the 384-pillar plate as
well as in the 96-well plate (Figure 4.8). All these data indicate that alginate and Matrigel
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used for encapsulation of RAW 264.7 cells on the micropillar chip and the 384-pillar plate
do not stimulate the cells, and the pillar plate platforms are well suited for rapidly

evaluating the immune response of RAW 264.7 cells with immunomodulatory compounds.
Importantly, the cytokines secreted into the 384-well plate were collected and measured
directly after removing the 384-pillar plate containing RAW 264.7 cells, avoiding multiple
washing steps in conventional ELISA assays, with greater efficiency and speed. Cytokine

secretion from RAW 264.7 cells after treatment with 1250 ug/mL of the N-glycan polymers

was assessed on the 384-pillar plate as it is another key feature in macrophage activation139.
Sialic acid-containing macromolecules were reported to affect the secretion of cytokine IL6 and IL-10 from murine and human macrophages29,140, indicating the potential of

exploiting inhibitory signaling by macrophage Siglecs as a tool for dampening
inflammatory141. The samples collected from the 384-well plate were examined by the
mouse cytokine 31-plex discovery assay to measure the levels of cytokine secretion. As a
result, most N-glycan polymers induced secretion of anti-inflammatory cytokines such as
IL-6, IL-10, and VEGF (Figure 4.9). Among them, N-a2,3-sialolactosyl polymer (9)

induced IL-6 secretion significantly (Figure 4.9A), N-galactosyl polymer (5) induced IL10 (Figure 4.9B) and VEGF (Figure 4.9C) secretion mildly, and N-glucosyl polymer (4)

and N-GlcNAc polymer (7) induced VEGF secretion (Figure 4.9C). These results further

confirmed the immunomodulatory effect of the N-glycan polymers on RAW 264.7 cells.
Thus, the 384-pillar plate could be used for high-throughput screening of cytokine secretion

activities of synthetic glycoligands on macrophages. The 384-pillar plate-based assay may
enable simultaneous quantitation of multiple secreted cytokines and could be an invaluable
high-throughput tool for the comprehensive study of immunomodulation.
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4.4 Conclusion
In summary, multiplex immune cell assays were established including cell viability,

the expression of cell surface markers, and the secretion of cytokines on the pillar plate

platforms upon stimulation of mouse macrophages with LPS and the N-glycan polymers.

Our pillar plate platforms offer unique advantages over conventional microtiter well plate
platforms for high-throughput screening of immune responses. First, the immune cell

encapsulation protocols established in alginate droplets on the micropillar chip and the 384pillar plate allowed convenient growth medium change without damaging the cells during
culture, prevented cell loss during extensive rinsing steps, and could be well suited for

encapsulation of non-adhesive immune cells. Second, high-throughput, high-content cell
imaging facilitated in situ on the pillar plate platforms allowed rapid assessment of

cytotoxicity and cell activation by compound treatment. Finally, the pillar plate platforms
required relatively small amounts of cells, compounds, and reagents for the assays, which

would be best suited for testing compounds in a scarce quantity. Currently, we are

developing immunofluorescence assays on the pillar plates with multicolor-labeled
antibodies (e.g., Alex488-anti-CD40 antibody, Alex402-anti-CD1D antibody, Alex532anti-CD80 antibody, etc.) to detect multiplex features of immune cells. Therefore, we

envision that our pillar plate platforms could be potentially used for a wide range of
immune cell-based assays for basic research, development, clinical diagnosis, and

screening applications.

101

CHAPTER V
SUMMARY

Over the recent decade, glycopolymers have continued to prove usefulness in various
applications across different scientific disciplines. The novel N-glycan polymer reported
above possesses a number of superiorities and applicability over existing counterparts.
CMFRP is a capable and attractive method for the synthesis of chain-end functionalized

N-linked glycopolymers, as it allows for direct polymerizations, reaction in aqueous

solution, exclusion of tedious protection and deprotection steps, and compatibility with a
broad range of aryl functional groups. This synthetic method can be applied to synthesize
polymers containing any kind of glycans, this includes monosaccharides, disaccharides and

trisaccharides, with controllable spacing and density, as well as alternative chain-end aryl
groups, such as aryl azide, aryl ethyne and aryl halides. The aryl azide chain-end
functionalized N-linked glycan polymers in particular were successfully developed as
photoactivatable glyco-ligands, and their application for affinity-assisted photo-labelling

of the specific protein was demonstrated with promising results.
Furthermore, attributed to their innate amphiphilicity, a small library of the novel

synthetic glycopolymers with monosaccharide and disaccharide pendent groups was
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investigated for dispersion of SWCNTs via non-covalent complexation in aqueous

condition. It was found that N-glycan polymers contained lactose pendent groups are
capable of effectively stabilizing SWCNTs to form water-soluble glycopolymer-wrapped
SWCNT complexes, depending on the carbohydrate density and polymer chain length.

This work demonstrated for the first time the synergistic effects of the identity of

carbohydrate pendant groups and polymer chain length of glycopolymers on stabilizing
SWCNTs in water. The novel N-glycan polymers not only attained respectable aqueous
dispersions of SWCNT, but their capability also surpass that of a conventional dispersant,

DNA-(GT)20.
Finally, immunomodulation effects of the novel N-glycan polymers on the model

mouse RAW264.7 cells were discovered using a newly developed high-throughput
multiplex assays on pillarplate platforms, with sialic acid-containing polymers displaying
relatively significant results. The pillar plate platforms reported above offer unique

advantages over conventional microtiter well plate platforms for high-throughput

screening of immune responses induced on RAW264.7 macrophages by the novel N-

glycan polymers. The immune cell encapsulation protocols established in alginate droplets
allow for convenient change of growth medium without the risk of cell loss or damages.
The high-throughput, high-content cell imaging aspects facilitate efficient assessment of
cytotoxicity and cell activation by compound treatment. The relatively small amounts of

cells, compounds, and reagents required for the assays allow for the testing of compounds

in a scarce quantity.

Glycopolymers are undoubtably a crucial class of biomaterials that deserves much
attention both in synthetic innovation and multidisciplinary utilization. Through this work,
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I demonstrated a feasible and reliable approach to synthesize glycopolymers with a wide

variety of capabilities for customization, which allows for tailored expression of both
carbohydrates and functional units. I also demonstrated utilization of glycoplymers across
multiple disciplines of science, from organic chemistry to biomedical engineering and

immunobiology. A comprehensive understanding of glycopolymer’s potentials still

remains unstudied and awaits extensive exploration in order to achieve new advances in

research, which ultimately is essential for the betterment of our future generations
biomedically.
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CHAPTER VI
FUTURE PERSPECTIVE

6.1 Novel N-glycan Polymers
6.1.1 Azide-Alkyne Cycloaddition Click-Chemistry
Click chemistry is a versatile reaction commonly used in bioconjugation to conjoin

a substrate or probe to a specific biomolecule of interest.142 In azide-alkyne cycloaddition,
azide is conjugated with a terminal or internal alkyne via triazole formation.143 With azide
or alkyne presented at the polymer chain end, an endless possibility of additional functional

groups can be added onto the glycopolymer for extra practicality. For example, a
fluorescent unit, such as BODIPY, can be added onto the polymer chain end to allow for
photoluminescence imaging or spectroscopic needs, which can provide added perspectives
to further study the glycopolymer’s reactivity dynamics in various events. Over the recent
years, clinical research has taken particular interest in the used of fluorescent

glycopolymers to characterize lectin-mediated bindings in vivo,144 especially in studies
concerning bacterial communications with respiratory cell surfaces or mucous
glycoproteins.145-147 Glycopolymers with intrinsic photoluminescence have been widely

accepted to be powerful probes for various biosensing applications owing to their real
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time, highly sensitive, and noninvasive characteristics.148 By conjugating BODIPY via
click chemistry onto the novel N-glycan polymers, the resulting fluorescent glycopolymers

will allow for easy visualization and quantification of specific receptor binding activities

upon treatment, as well as the pinpointing of receptor locations and tracing of carbohydrate
transportation among many other benefits.

The most widely employed approaches for azide-alkyne click-chemistry can be

categorized into either copper-catalyzed or copper-free strain-promoted reactions
depending on the intended alkyne target.149 Using cyclooctyne as the internal alkyne target

for azide, copper-free click chemistry can be employed (Scheme 3), which allows for a fast

and painless cycloaddition that can be carried out at room temperature. Alternatively, if

ethynylaniline was incorporated as the initiator in CMFRP (Scheme 4), aryl alkyne chain
end functionalized glycopolymers can be constructed to offer a terminal alkyne that is
readily capable of copper-catalyzed click-chemistry onto an azide target.150

As the most widely-used participant in click chemistry, the azide functionality can
be easily introduced onto molecules of interest using either an azide salt or an azide with
an aminated tail.41,43,151 One example is in the modification of recombinant proteins where

azide functionalization will permit click chemistry for additional augmentation.151

Specifically, a recombinant domain-selective form of the cell membrane protein thrombomodulin functionalized with azide, can benefit from a site-specific artificial

glycosylation using aryl alkyne chain-end functionalized glycopolymers. The aryl alkyne

chain-end functionalized sialyl-glycopolymers will specifically allow for sialylation of the
azide functionalized recombinant thrombomodulin, effectively enabling site-specific
glyco-engineering that produces a thrombomodulin-chondroitin sulfate mimetic as a

106

potentially effective and reliable anticoagulant protein remedy for the treatment of
thrombotic diseases.
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Scheme 3. Fluorescent labeling of aryl azide chain-end functionalized N-glycan polymers via Copper-Free Click Chemistry.
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Scheme 4. Aryl alkyne chain-end functionalized N-glycan polymers.
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6.1.2 Dual Chain-end Functionalization

Other than the aryl chain end of the glycopolymer, the O-cyanate chain end is also
capable of modification to allow for further augmentation. A variety of different reactions

can take place at -OCN to form useful organic conjugates. One of the most prominent
examples is the isourea bond formation with an amine target.46 Either with a small molecule
functional unit containing primary amine, or with an amine-coated platform or bead
surface, the O-cyanate chain end can effectively act as the anchor point for conjugation.

Particularly, one example is the possibility of biotinylation of the glycopolymers using
Biotin-PEG2-Amine (Scheme 5). The primary amine of Biotin-PEG2-Amine allows for

isourea bond formation of the -OCN at the chain-end of the glycopolymers, this
modification effectively enables dual chain-end functionalization with an aryl unit at one

end and a biotin unit on the other.
The introduced biotin on the glycopolymer chain-end will allow for protein target

pull-downs, following the glycopolymer’s specific carbohydrate affinity assisted target

selections. The well-known biotin-streptavidin interaction will facilitate precise protein
isolations for further study and research,152 particularly in protein detection where

purification, elution, and expression level profiling can be made effortless.152 The
involvement of biotin unlocks a wide spectrum of possibilities for different proteomic
assay strategies ranging from protein microarrays to immunoprecipitations. With dual

chain-end anchoring capabilities, the novel glycopolymers can be used in various types of

bead-based or immunosorbent protocols, enabling them to become a multifaceted tool for
comprehensive research in specific glycan-protein interactions.
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Scheme 5. Biotinylating of chain-end functionalized N-glycan polymers via isourea bond formation.
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6.2 Aqueous Dispersions of SWCNT by Alternative Disaccharide Polymers
It was found that glycopolymers expressing monosaccharides did not produce
effective dispersions of SWCNTs. When glycopolymers expressing disaccharide lactose

were introduced, well-dispersed SWCNTs were obtained. It was rationalized that the steric

effects of lactose’s pyranose rings played a role in contributing to polymer backbone’s
stable wrapping mechanism, which allowed for SWCNT aqueous dispersions. I

hypothesize that other disaccharides could impose a similar effect, therefore, the logical

next step moving forward would be to study glycopolymers expressing other types of
disaccharides or even tri-saccharides, including kojibiose, maltose, cellobiose, melibiose,

and sialic acid, for their contrast and similarity with lactose glycopolymers in order to

further identify the most capable carbohydrates for the construction of glycopolymers that

could yield the most promising dispersions of SWCNT.

6.3 Immunomodulation of the Novel Sialyllactosyl N-Glycan Polymers
To obtain useful understanding in immunomodulation that will eventually benefit

healthcare, a model cell target originated in humans would be a more suitable and
representative subject of choice. THP-1 is a human leukemia monocytic cell line that has

been extensively used to study monocyte/macrophage functions, mechanisms, signaling
pathways, and nutrient or drug transport. This cell line has become a common model to
estimate modulation of monocyte and macrophage activities, because it provides several

advantages over tissue resident or peripheral blood mononuclear cell (PBMC) derived

macrophages due to its relative ease of access, long-term storage capability, fast growth
rate, relative homogeneity with the same genetic background, and the absence of

contaminating cells.27,153,154
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The future of this research will utilize THP-1 monocytes derived macrophages to
elucidate immune cell responses following treatments of sialylated stimuli. I hypothesize

that the novel sialyllactosyl N-glycan polymers will be able to activate Siglec-9, Siglec-11,

and Siglec-14 expressions39,155,156 specifically on the surface of cells both in cis and trans
approaches to initiate inhibitory signal transduction. Recognition of sialic acids by Siglecs

will be particularly dependent on the point-to-point saccharide linkage, a2,3 and a2,6, with

different Siglec receptors having distinct binding preferences. Particularly, Siglec-9 is an
inhibitory receptor readily expressive on THP-1 differentiated macrophages with a
preferential affinity to a2,3-linked sialic acids.39,115,157 By targeting and artificially

activating cell surface Siglec-9 using a2,3 sialylated polymers, I hypothesize that
inflammatory responses of macrophages will be attenuated. Sialylated glycopolymers will
potentially exhibit an advantage over sialylated nanoparticles, because of their biomimetic

properties and ability to display either a2,3 and a2,6 sialyllactose linkages much like their

expressions in natural glycan.
To evaluate sialylated polymer’s anti-inflammatory effects when bound with

Siglec-9, I will first confirm the adequate expression of Siglec-9 on the target cell line.

PMA differentiated THP-1 cells will be stimulated with LPS, then lysed for the extraction
of mRNA. After conversion to complementary DNA, Siglec-9 gene expression can be

confirmed by real-time PCR. In addition, the cell surface expression level of Siglec-9 can
also be examined by commercially available FITC-labeled human Siglec-9 monoclonal
antibodies using flow cytometry analysis and confocal microscopy. With the confirmation

of Siglec-9 expression on THP-1 derived macrophages, the next step will be to introduce

sialylated polymers along with LPS as stimuli to cell targets for the evaluation of induced
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cell surface markers by flow cytometry and cytokine release by ELISA, unveiling
sialylated polymer’s anti-inflammatory properties.
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